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Abstract 
 
Title:   Development and Characterisation of Solid-State Ion- 
  Selective Electrodes, and their Application to Sweat  
  Analysis for Cystic Fibrosis Diagnosis. 
Author:  Aogán Lynch 
 
Cystic Fibrosis (CF) is one of the most common genetic diseases affecting 
Caucasians that leads to early deathi.  It is Ireland’s most common life-
threatening inherited disease.  Early diagnosis facilitates early 
implementation of therapy, which can significantly improve the prognosis 
and life quality of the affected patient.  The gold standard diagnostic test for 
CF is the Quantitative Pilocarpine Iontophoresis Test (QPIT) for the sweat 
electrolytes sodium and chlorideii.  In the QPIT, the sweat glands are 
artificially stimulated, a sweat sample is collected, and the concentrations of 
sodium and chloride ions determined separately using standard benchtop 
analytical instrumentation.  In this thesis, the use of miniature solid-state 
Ion-Selective Electrodes (ISE’s) to monitor both target ions simultaneously, 
for the purpose of CF diagnosis, is investigated.  A commercially available 
sensor array in a flow-cell was initially used in both simulated and live 
clinical trials, involving the analysis of real sweat samples from confirmed 
CF and non CF populationsiii.  Solid-state ISE’s were then designed, 
constructed, tested and incorporated into a bespoke flow-cell device 
compatible with modern sweat sampling equipment.  Finally a working 
prototype of a wearable, watch-type device for the rapid on-line diagnosis of 
(CF) was designed, constructed and employed in a live clinical trial to 
assess its usefulness as a possible real-world diagnostic / screening device.   
                                                 
i
  Committee for a Study for Evaluation of Testing for Cystic Fibrosis;  
Journal of Pediatrics, 1976, 88, 4, Part 2, 711-750 
ii
  L.E. Gibson, R.E. Cooke; Pediatrics, 1959, 23, 545-549. 
iii
  Lynch, D Diamond and M Leader; Analyst, 2000, 125, 2264-2267. 
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1 Cystic Fibrosis  
 
1.1 Introduction 
 
Cystic Fibrosis (CF) is one of the most common genetic diseases affecting Caucasians 
that leads to early death1.  It occurs in approximately 1 in every 2500 live births and 
has a carrier incidence of ca 4-5 %.  The symptoms of CF vary greatly in their 
severity, but include pulmonary and respiratory disease, malnutrition, pancreatic and 
hepatic insufficiency, and sterility, leading ultimately to premature death.  Affected 
patients may die in the neonatal period or in early childhood, but only in rare cases do 
patients survive to middle age.  The diagnosis of CF is an important issue, as with any 
disease, because the early implementation of therapy can significantly improve the 
prognosis and life quality of the affected patient.  The gold standard diagnostic test for 
CF, introduced by Gibson and Cooke2 in 1959, is the Quantitative Pilocarpine 
Iontophoresis Test (QPIT) for the sweat electrolytes sodium and chloride.  In the 
QPIT, the sweat glands are artificially stimulated, a sweat sample is collected, and the 
concentrations of sodium and chloride ions determined using standard bench-top 
analytical instrumentation.  This study investigated the simultaneous determination of 
both target ions, using a commercially available sensor array in a flow-cell, 
manufactured by SendX® Inc.  The suitability of the device for the analysis of sweat 
samples was assessed by first applying it to the analysis of simulated samples in the 
expected normal, borderline and CF diagnostic concentrations ranges.  A clinical trial 
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was then carried out involving the analysis of real sweat samples from both a normal 
and a CF-positive population. 
 
 
1.2 Cause of CF 
 
CF is caused by a mutation in the gene which codes for the cystic fibrosis 
transmembrane conductance regulator (CFTR).  The CFTR gene was described by 
Lap-Chee Tsui et al., in three seminal papers in Science in September of 19893,4,5.  
The CFTR itself is a protein of 1480 amino acids, which functions as a chloride 
channel, but mutations in the gene, which codes for this protein, render the resultant 
protein defective.  To what extent it is defective is dependant on the mutations 
present.  Around 70% of the CF positive population exhibit Lap-Chee Tsui et al’s 
demonstrated mutation, a deletion of 3 base pairs coding for phenylalanine at amino 
acid position 508 in the predicted protein, and this mutation is termed ∆F508.  Many 
other mutations have since been, and continue to be, discovered and the current 
number of known mutations (as of April 2010) is in excess of 16006, although not all 
are disease causing. 
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1.3 Effects of CF 
 
CF results in a general increase in the viscosity of bodily secretions.  The regulation 
of ion transport across epithelial cell membranes is affected, resulting in non-
functional chloride transport and sodium reabsorption.  This leads to increased 
viscosity of bronchial secretions, which impairs airway clearance and increases the 
risk of infection1.  The resultant chronic pulmonary disease characteristic of CF 
initially gave rise to the term “mucoviscidosis” for the condition, and it is the leading 
cause of lung damage and death in CF sufferers.  Chronic and irreversible 
colonisation of the lungs by bacteria such as Staphylococcus Aureus often occurs 
initially, followed by Pseudomonas Aeruginosa.  These recurrent and persistent 
infections, together with by-products of the organism-neutrophil interactions with the 
body’s immune system, clog the lungs in the already abnormally viscous airway 
secretions.  Other secretions are also affected; indeed another term given to CF was 
“fibrocystic disease of the pancreas” due to the fact that 85-90% of all patients exhibit 
some form of exocrine pancreatic insufficiency7.  The pancreas functions in part as an 
exocrine gland, secreting enzymes into the gut to aid digestion.  CF exocrine 
secretions are abnormal, leading to obstruction of the pancreatic ducts, preventing the 
secretion of these digestive enzymes into the stomach thus leading to malabsorption 
of fats and proteins and poor weight gain.  Similar secretory abnormalities lead to 
sterility in males due to obstruction of the Vas Deferens; but perhaps the most 
important manifestation, diagnostically at least, of this chloride channel failure is the 
elevated sodium and chloride levels in the sweat of CF affected individuals identified 
by Di Sant’Agnese et al. in 19538, as a result of a heat wave in New York in 1948.  A 
positive sweat test for CF occurs when sweat sodium and chloride levels are equal to, 
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or greater than, 50mM and 60 mM respectively.  Normal levels should be below these 
thresholds.  
 
 
  
1.4 Diagnosing CF 
 
The gold standard test for CF, introduced in 1959, is the Gibson and Cooke QPIT 
(Quantitative Pilocarpine Iontophoresis Test) based on the characteristic elevated 
levels of sodium and chloride in sweat (≥50mM sodium and ≥60mM for chloride)2, 
This diagnostic test is still in use today. Suspicion of CF may arise from the 
knowledge of a family history of the disease, or from one of many available screening 
tests (where they are in place), or from clinical presentation.  Though CF is a well-
characterised disorder, diagnosis is not always straightforward9 for many reasons, 
some of which are discussed below.  In all cases, however, the QPIT remains the 
definitive and only accepted confirmatory diagnostic procedure for the disease.   
 
The classic presentation of CF is a child with respiratory disease, and malabsorption 
due to pancreatic insufficiency – “failure to thrive”.  A standard QPIT for elevated 
sodium and chloride in sweat usually confirms CF, and the test should be carried out 
in triplicate for validation.  A correctly performed sweat test has ca. 98% accuracy10.  
Where diagnostic difficulty arises is in atypical cases relating to novel and unusual 
CFTR gene mutations where sweat electrolytes are borderline or normal; or when 
neonatal diagnosis is required.  There are many examples of such atypical cases in the 
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literature where clinical presentation is suggestive of CF and mutation analysis 
identifies CFTR mutations but sweat test results are persistently normal11,12,13.  Such 
cases are relatively rare, however, and in >98% of cases the sweat test is accurate.  A 
positive sweat test and the identification of 2 CF mutations is a clear diagnosis of CF 
in most cases.  In atypical cases a repeat of the QPIT and thorough evaluation of the 
respiratory system, pancreatic sufficiency and liver functions, as well as an extended 
search for rare mutations is required.   
 
Neonatal diagnosis is important because early diagnosis means early implementation 
of preventative and palliative treatment.  Neonatal diagnosis is difficult because the 
cornerstone QPIT cannot be carried out on newborns, as they do not sweat sufficiently 
in the first 6 weeks of life to facilitate sample collection.  Even after those 6 weeks the 
QPIT is at any rate considered too laborious and expensive a test for blanket screening 
of all newborns.  Current screening methods include the measurement of Immuno-
reactive Trypsin (IRT) in the blood of neonates14, CFTR mutation analysis, pancreatic 
sufficiency tests for meconium albumin15, and sweat conductivity tests16.  These tests 
all have their advantages but they are only screening tests, and any positive results 
indicative of CF must be followed up with a standard QPIT.   
 
As has been said, the current number of identified mutations is in excess of 1600, 
though the vast majority occur at a frequency of less than 0.1% in the affected 
population6.  This hampers the screening for the disease via the genetic route as it is 
difficult and expensive to screen every individual for every possible mutation.  
Selectively screening for a small number of the most common or likely mutations can 
be carried out but the results depend on the mutations screened for, and indeed on the 
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population being screened.  The most common mutation in the UK is the three base 
pair deletion, ∆F508, which accounts for approximately 75% of carriers.  The same 
mutation appears in approximately 90% of the CF cases in the United States17.  
Commercial multiple-mutation assays are available that can detect about 86% of 
carriers in Scotland, Wales and the North of England, or 80% elsewhere.  Different 
proportions apply to other populations such as Asians (35%), Ashkenazi Jews (95%) 
and African Americans (41%)18.  Clearly, the detection rate of DNA mutation testing 
is highly dependent on racial and ethnic background.  No consensus exists as to the 
best multi-mutation screening panel to use because the frequency distribution of 
CFTR mutations varies across racial and ethnic groups19.  Ethnic variation is not an 
issue with the standard QPIT test for sodium and chloride in sweat. 
 
 
1.5 The Sweat Test 
 
The QPIT is widely regarded as one of the best diagnostic tests in clinical medicine20.  
It consists of three separate stages:  
 
(i) stimulation of sweating by pilocarpine iontophoresis  
(ii) sample collection e.g. onto gauze or filter paper or the Wescor 
Macroduct®  (see Figure  1.1b & c), and  
(iii) analysis for sodium or chloride or both.   
 
 8 
Stimulation of sweat is carried out by pilocarpine, a cholinergic drug, introduced to 
the skin by iontophoresis to induce sweating in a localised area.  The pilocarpine is 
purchasable in convenient “use once and throw away” gel disks compatible with the 
iontophoresis unit available from the same company – ACCU Science, Ireland – a 
division of Wescor Inc. (Logan, Utah 84321 USA).  Pilocarpine, activated by a low 
voltage electrical current, is drawn into the dermal layer of the skin where it 
stimulates the sweat glands, activating their secretion [Figure  1.1a].  Sample 
collection is carried out using filter paper or gauze, or another Wescor device called 
the Macroduct® [Figure  1.1b & c].   
 
 
 
Figure  1.1 Following iontophoresis with pilocarpine to stimulate sweating (a), the 
sweat is collected using the Macroduct® unit which is strapped over the stimulated 
region like a wristwatch (b).  The neat sweat collects in a coiled tube through a hole in 
the back of the unit.  (c) A blue marker dye is used to indicate the progress of the 
sweat collecting in the tubing (image taken from www.wescor.com). 
 
 
It is equally accepted, however, that the QPIT is difficult to perform, laborious, and 
notoriously prone to errors if not executed correctly with strict adherence to 
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procedure21, leading to higher incidences of false positive and negative results.  For 
this reason, many efforts have been made to simplify and speed up the standard 
procedure while cutting the cost of it, in order to make it more suitable to both mass 
screening and less frequent use, in hospitals as well as centralised CF centres.   
 
On-skin ion selective electrodes (ISE’s) have been used22,23,24 for on-skin sweat 
analysis after stimulation to eliminate the sample collection and weighing stages and 
their associated problems, but in general these devices have performed rather poorly 
due to problems with evaporation of the sweat during sampling, poor reproducibility, 
contamination of sample by leakage from the liquid junction of the reference 
electrode, difficulty in achieving good contact with the skin surface and mV-signal 
artefacts arising from pressure changes or patient movement etc.   
 
The Scandipharm Cystic Fibrosis Indicator System (CFIS) chloride patch25,26 is 
another diagnostic device consisting of a filter paper patch placed over the site of 
iontophoresis.  The sweat is absorbed and meets a “chloride-complexing chemical” to 
form a precipitate and the circumference of the precipitate ring is related to the 
concentration of chloride.  A number of devices based on conductivity measurements 
also exist and are in use, most notably the Wescor Sweat Chek® conductivity meter, 
which is the only screening test approved by the United States Cystic Fibrosis 
Foundation.  Again, however, as with all of the above tests, it remains a screening test 
only, and is not accepted as a valid diagnosis without a confirmatory QPIT.   
 
One of the most significant sources of error in the QPIT sweat test is the sample 
collection stage which involves the use of pre-weighed filter paper or gauze to be 
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placed over the site of iontophoresis for a period of 30 minutes to absorb the sweat 
being produced.  This procedure is fraught with the problem of evaporation and 
resultant concentration of the sample during collection and also during transfer of the 
filter paper to a stoppered flask for re-weighing.  These problems were significantly 
improved by the development of the Wescor Macroduct® system27,28.  As shown in 
Figure  1.1, the Macroduct® is strapped to the site of iontophoresis (usually the 
patient’s arm), the sweat collects in the shallow concave region underneath of the 
plastic disk and through the hydraulic pressure of the sweat glands (stimulated by the 
action of pilocarpine) the sweat is forced into the coiled capillary tubing via a small 
hole in the centre of the disk connected to a collection coil of plastic tubing.  A spot of 
blue dye at the entrance to the coil is taken up by the sweat and aids visualisation of 
the collection process.  Wescor Inc. encourages the coupling of the Macroduct® with 
its own commercially available Sweat Chek® conductivity meter, but as a sweat 
sample collection system it can of course be coupled with any subsequent analytical 
technique.  The advantage of the Macroduct is it facilitates easy collection of up to 75 
µg of liquid sweat while eliminating traditional sweat test difficulties with 
evaporation.  After collection the device can be dismantled and the sample extracted 
using a syringe and transferred to an appropriate vial for storage or analysis.   
 
ISE analysis of samples collected via the Macroduct has been successfully carried out 
and found to be a valid alternative29.  In this study, the use of a miniature ion-selective 
electrode array to analyse sweat samples and therefore diagnose CF, is proposed.  The 
device, manufactured by SendX® Inc, a commercially available blood gas and blood 
electrolyte analyser was investigated as an analytical system for liquid sweat samples 
collected via the Macroduct.  As the device is basically a series of miniature sensors 
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in a flow-cell, it is capable of analysing small volumes of any compatible liquid 
sample that can be pumped through the device, for a variety of analytes.  The ability 
to simultaneously analyse sodium and chloride is also a big advantage.  Many current 
sweat analysis techniques such as flame photometry and anion exchange 
chromatography have several major disadvantages for occasional users in physician’s 
offices or hospital outpatient departments30.  They require relatively sophisticated and 
expensive analytical instrumentation and a high degree of technical competence to 
operate them.  This is especially true when undertaking the determination of both the 
sodium and chloride levels in sweat samples, as is recommended for optimum 
reliability31.  This would most likely necessitate the splitting of sweat samples into 
two portions for the different methods of analysis for the two ions and, almost 
certainly, dilution of samples to ensure sufficient volumes for replicate analyses.  This 
makes the analytical procedure lengthy and tedious. Using a microelectrode array 
allows, in principle, the simultaneous analysis of sodium and chloride (as well as 
potassium if required).  No bulky or expensive instrumentation is required, and it is 
quite simple to use.  Multi-component analysis using micro-sensor arrays is attractive 
as it reduces both analysis time and expense.  It also presents a more convincing 
assay, as contributions from other components in the same sample matrix can be 
investigated simultaneously.  Furthermore there is a rapidly growing demand for 
devices which allow 'point of need measurements' rather than sending samples to 
centralised analytical laboratories.  The use of sensor arrays such as the SendX® array 
used in this study offers a convenient route to achieving this goal. By simply passing 
samples through the array, delays associated with collection and storage and eventual 
analysis are minimised.  In preliminary studies, it was identified that CF diagnosis 
could in principle be performed with an array of this type, as the marker ions (Na+ and 
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Cl-) present in sweat can be easily and accurately measured by reconfiguring sensor 
arrays produced for blood analysis32, 33. 
 
This chapter describes the assessment of the suitability of the array for the analysis of 
sweat samples by applying it to the analysis of simulated samples in the expected 
normal, borderline and CF diagnostic concentrations ranges.  A clinical trial was 
subsequently carried out involving the analysis of real sweat samples from both a 
normal and a CF population, and this is described in the following chapter.  
 
 
1.6 Experimental 
 
2 litres of a mixed 0.1 mol l-1 (100 mM) stock solution of potassium, sodium and 
chloride was made up (14.912g KCl and 16.998g of NaNO3) and diluted to give 0.02, 
0.04, 0.06, 0.08 and 0.1 mol l-1 standard solutions.  Four simulated samples were also 
made up containing all three ions of interest at equal concentrations of 0.035, 0.050, 
0.075 and 0.085 mol l-1 and numbered 1 to 4, respectively.  Analytical grade 
potassium chloride and sodium nitrate were obtained from Fluka Chemie AG and 
used to make up the simulated samples and standards.  Ultrapure water (Barnstead 
EASYpure RF Ultrapure water system, 18.2MΩ-cm resistivity) was used throughout 
this study.   
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1.7 Instrumentation  
 
The sensor array was received from SendX Inc as pictured in Figure  1.2.  A Gilson 
Minipuls 3 peristaltic pump connected to the array with microbore capillary tubing 
was used to pump standard and sample solutions through the flow-cell. Signals from 
the sensors were transferred after impedance conversion to a portable PC, via a 
National Instruments DAQ-Card AI-16XE-50 I/O data acquisition card.  The 
multichannel data was captured and displayed using LabView software written in-
house.   
 
Figure  1.2 SendX Array. The top image shows the sensor array and the transparent 
plastic flow-cell in which it is encased. Below it is the same array pictured side-on 
showing the 24-pin-out arrangement underneath the array.  
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The digital data acquired from each sensor were displayed simultaneously as real time 
millivolt readings on the PC screen, and saved as ASCII text files.  Microsoft Excel 
was used for post-acquisition data analysis and for graphical representation of the data 
obtained.   
a
b
c
 
Figure  1.3 CF analytical system: The signals taken from the array (a) are routed 
through a shielded box containing an impedance conversion circuit (b). This is 
connected to a mini-PC running a LabVIEW program which captures the signals and 
plots voltage response against time (c). 
 
 
1.8 Procedures 
 
A Gilson Minipuls 3 peristaltic pump connected to the array with microbore capillary 
tubing (0.1 mm internal diameter) was used to pump standard and sample solutions 
through the flow-cell.  The sensor array was obtained from SendX® and connected to 
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a portable PC via an impedance conversion circuit housed in an rf-shielded box.  
Signals from the sensors were transferred after impedance conversion to a portable 
PC, via a National Instruments Lab-PC 1200 data acquisition card.  The multichannel 
data was captured and displayed using LabView software written in-house.  The 
digital data acquired from each sensor were displayed simultaneously as real time 
millivolt readings on the PC screen, and saved as ASCII text files.  Microsoft Excel 
’98 was used for post-acquisition data analysis and for graphical representation of the 
data obtained.  
 
 
1.9 Results and discussion 
 
 Figure  1.4 shows one of the LabView user interfaces employed in the study.  This 
relatively simple interface displays three sensor signals (Na+, K+ and Cl-).  In each 
case, the baseline is shown to be stable, exhibiting minimal drift and hysteresis, 
particularly for the Na+ and K+ sensors.  The baseline represents the 0.01 mol l-1 
standard while the responses from left to right are the 0.02, 0.04, 0.06, 0.08 and 0.1 
mol l-1 standard solutions.  Figure  1.5 shows the same calibration sequence followed 
by analysis of the simulated samples (0.035, 0.050, 0.075 and 0.085 mol l-1 mixtures 
of Na+, K+ and Cl-, numbered 1 to 4 respectively) analysed in a random order  (#2, 4, 
3, 1, 3, 2, 2, 3, 4, 1, 4, and 1.)  
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Figure  1.4 LabView Virtual Instrument Interface showing real-time responses to 
standards containing 20, 40, 60, 80 and 100 mM sodium, potassium and chloride.  
Baseline is a solution, which is 10 mM in all three ions.  Sodium is the topmost trace, 
potassium the middle and chloride the bottom. 
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Figure  1.5 Extended data display of three data channels after importation in to 
EXCEL.  The first 5 response peaks represent the 5 standards (0.02, 0.04, 0.06, 0.08 
and 0.1 mol l-1 in all three ions) against the base line (0.1 mol l-1) in each case, 
random unknowns (1 to 4, see text for details) follow. 
 
The response was seen to be very rapid, and a steady-state signal was obtained almost 
immediately.  The return to the 10 mM baseline is equally fast, with minimal tailing, 
drift or hysteresis (Figure  1.5).  It must be noted that the above trace is not 
representative of continuous, flow-injection analysis.  The data collection software 
was paused during each solution changeover.  Sample turn-around, including flushing 
and filling of the array with the solutions, was approximately 1 minute.  However, this 
could be further shortened if the array was used in flow-injection mode, and 
considerably shorter flushing times could also be used as the dead volume of the array 
is only ca 40 µl.  The calibration curves (Figure  1.6) generated from the data in Figure 
 1.5 show good linearity for each of the electrodes.   
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 Na + y = 55.789x + 114.73
R2 = 0.999
 K +   y = 61.348x + 112.91
R2 = 0.9996
 Cl -  y = -36.045x - 73.252
R2 = 0.9943
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Figure  1.6.  Calibration curves for Sodium, Potassium and Chloride.  The unfilled 
symbols are standards, the filled symbols are unknowns.  Y error bars were calculated 
for standards and samples but were sufficiently small as to be invisible in this graph at 
this scale (see Table  1.1). 
 
The unfilled symbols signify the five standards and the filled points represent the 
unknowns.  An excellent correlation was obtained in each case, but the slope of the 
AG/AgCl electrode was sub-Nernstian to Cl- at ca. –36.1 mV/decade.  Later work 
seems to show that this was peculiar to the chloride electrode in this array only.  
Devices received and used in later work subsequently yielded Nernstian slopes for 
chloride. 
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Electrode    Standard 
     20mM       40mM       60mM        80mM     100mM 
 
K+    8.63  (0.08)  27.38 (0.08)  37.51 (0.06)  46.05 (0.08)  51.39 (0.07) 
Na+   19.48 (0.04)  37.47 (0.05)  46.70 (0.04)  53.57 (0.14)  58.50 (0.01) 
Cl-  -12.09 (0.05) -22.38 (0.01) -30.25 (0.02) -32.78 (0.10) -37.51 (0.19) 
 
Table  1.1 Steady state values in mV used to generate the calibration plots. The 
calibration regime was only carried out once, but for each standard the steady state 
reading was monitored for 30 seconds, with the system automatically recording a 
reading every second. The deviation of the response for each electrode over those 30 
seconds was calculated and is included here (in brackets after the average mV reading 
for each electrode and standard) to demonstrate the stability of the signals. All show a 
deviation of less than 0.2 mV and all but 2 are less than 0.1 mV. 
 
 
 
sample K+ Na+ Cl-
1 2 3 σn=3 1 2 3 σn=3 1 2 3 σn=3
35mM 27.88 28.27 27.99 0.20 34.05 34.50 33.98 0.28 -20.30 -20.94 -19.61 0.67
50mM 36.28 35.65 35.62 0.37 42.87 43.18 42.95 0.16 -26.03 -25.95 -25.92 0.06
75mM 44.24 44.02 43.71 0.27 52.29 52.31 51.91 0.23 -33.55 -32.38 -32.07 0.78
85mM 47.71 47.72 47.10 0.36 54.83 55.12 54.60 0.26 -35.84 -35.70 -35.42 0.21
 
Table  1.2 Triplicate millivolt responses of each of the three electrodes to the four 
simulated sample solutions, along with calculated n=3 standard deviations. These data 
were used to estimate the sample ion concentrations from the calibration curves, 
presented in Table  1.3. 
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            Electrode 
True sample        K+   Na+   Cl- 
concentration 
35mM   41.37    (18.2%)  35.99    (2.8%) 33.95   (-3.0%) 
50mM   55.45    (10.9%) 51.79    (3.6%) 48.77   (-2.5%) 
75mM   75.27     (0.4%) 75.62    (0.8%) 74.88   (-0.2%)  
85mM   85.90     (1.1%) 84.46    (-0.6%) 86.94    (2.3%) 
 
Table  1.3 A comparison of the true sample values with those estimated from the 
calibration curves. Relative percentage errors between the true and estimated sample 
concentrations are also shown. 
 
 
From the data in Table  1.2 and the results obtained from the calibration curves in 
Table  1.3 it can be seen that the best results were obtained for sodium with a very 
good level of accuracy as reflected in the relative percentage error values, and good 
precision also with low mV standard deviations (≤ 0.28 mV); i.e. results obtained 
using the array correlated very well with the known concentrations of sodium in the 
samples. The results for chloride were also encouraging, though less consistent.  The 
results for potassium show slight inaccuracies in the lower concentration samples. The 
slope exhibited by the potassium electrode was higher than the expected slope (61.35 
mV/decade) and the potassium results also show a larger than expected value for the 
lowest unknown (0.0409 mol l-1 instead of 0.035 mol l-1).  This may be an outlier, as 
the other unknowns are all determined to an accuracy of less than 1.0 x10-3 mol l-1, 
and the triplicate mV data for that “35 mM” solution are very consistent; therefore the 
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error could simply be a dilution or similar practical error in the making up of the 
solution.   
 
The concentrations of sodium and chloride used in this study are typical of those 
found in sweat and used to diagnose cystic fibrosis34.  The most appropriate 
thresholds are a matter of some debate.  Generally ≥50mM sodium and ≥60mM for 
chloride is considered diagnostic for CF as originally suggested by Gibson and Cook 
in 19592, but other investigators have suggested revision of these thresholds.  For 
example, one study of 233 children35 found that all CF positive children had chloride 
>80 mM and sodium >50 mM, while normal children all had chloride <40 mM and 
sodium <50 mM.  Whatever the thresholds, these results suggested that the array 
could be adapted for this diagnosis.  If the performance of the array is assessed on the 
basis of, for example, the Gibson and Cooke levels, the 35 mM simulated sample 
would be representative of a sample taken from a normal population, the 50 mM 
would a normal borderline, and the 75 mM and 85 mM would be considered (as part 
of a full clinical assessment) to be diagnostic of CF.  From Table  1.3, which compares 
the known concentrations of the samples with those estimated from the array data, the 
close agreement of between the 2 sets of data, with an average %error of < 2% for the 
sodium and chloride electrodes indicates that the array might well be used to analyse 
real sweat samples with sufficient accuracy to differentiate between normal samples 
and CF samples, based on the expected marker ion concentrations and their accepted 
diagnostic thresholds.  
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1.10 Conclusions 
 
Commercially available sensor arrays primarily aimed at the blood gas market can be 
easily adapted for other applications.  Portable instruments capable of rapid 
multicomponent analysis can be produced by coupling the blood analyser arrays to 
portable PCs fitted with data acquisition cards.  The Labview software development 
environment enables sophisticated graphical user interfaces to be rapidly produced 
and customised for particular applications.  The analytical results demonstrate that the 
array can easily be calibrated and used for assays outside the normal range employed 
in blood analysis.  They also show that the cell can be used as a component in a 
portable instrument suitable for simultaneous multi-sensing of ion mixtures.  The 
success of this study in the accurate determination of the CF marker ions in simulated 
positive and negative sweat samples in the expected concentration ranges for real-life 
samples was very encouraging.  
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2.1 Introduction 
 
The work described in chapter 1 demonstrated the successful employment of the 
Sendx® array in the detection and monitoring of the electrolytes indicative of, and 
over the concentrations relevant to, a cystic fibrosis (CF) diagnosis.  This indicated 
that the array might be applicable to the analysis of real sweat samples for diagnosing 
CF.  This chapter describes the use of that same analytical set-up in a CF clinical trial 
involving real sweat samples collected from both CF positive and normal populations.  
The analytical performance of the array was referenced against standard bench-top 
Ion Chromatographic and Atomic Absorption Spectroscopic methods. 
 
 
 
2.2 Experimental 
2.2.1 Reagents and Instrumentation 
Analytical-reagent grade potassium chloride and sodium nitrate were obtained from 
Fluka Chemie AG and used to prepare sample and standard solutions.  Ultrapure 
water (Barnstead EASYpure RF Ultrapure water system) was used throughout.   
 
All sweat samples were collected by pilocarpine iontophoresis using a Macroduct 
3700-SYS Sweat Collection system obtained from Wescor.  Ion chromatography was 
carried out using a Dionex DX-120 ion chromatograph.  AAS for potassium and 
sodium was carried out on a Perkin Elmer Model 3100 atomic absorption 
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spectrometer.  The same analytical system was employed as in the previous chapter 
(Chapter 1)  
 
 
2.2.2 Procedures 
Sample Collection: 
The normal and CF positive sweat samples were collected on-site in Dublin City 
University and in the CF Clinic in Our Lady’s Hospital in Crumlin, respectively.  
Ethical approval was sought from and granted by the hospital ethics committee prior 
to the trial.  This facilitated attendance of the morning outpatients’ CF clinic in the 
hospital, which takes place on an almost weekly basis.  Patients regularly attend such 
clinics for routine tests such as respiratory function and nutrition to assess their 
general progress as well as any specific issues, which might arise.  In the waiting 
room of the clinic, patients and their parents were approached, and their participation 
in the trial requested.  The aims of the trial and the nature of the sweat test were 
explained and any other questions or concerns answered.  Given the parents’ and or 
patients’ consent, a sweat sample was collected via the standard QPIT (Quantitative 
Pilocarpine Iontophoresis Test) method.  The equipment and method used are 
described below.   
 
A Macroduct 3700-SYS Sweat Collection system was used to collect the samples.  
This is a complete system for sweat sample collection.  It consists of the “Webster 
Sweat Inducer” (see Figure 2.1a).  This is basically a sophisticated battery pack with 
two electrodes and a 5-minute timer.  Wescor also manufacture and provide Pilogel® 
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discs, solid aqueous based gel discs containing 0.5% pilocarpine nitrate which fit into 
the electrodes as shown in Figure 2.1b .  
 
Figure 2.1 (a) The “Webster Sweat Inducer” available from Wescor and (b) the 
Pilogel® discs as they fit into the electrodes (images taken from www.wescor.com) 
 
For each patient, the site of iontophoresis (usually the patient’s arm) was cleaned with 
deionised water, and the electrodes, fitted with fresh pilogel® discs, were strapped to 
the chosen limb, a couple of inches apart, with Velcro straps (provided) as previously 
described and illustrated in chapter 1, Figure 1.1.  The Webster Sweat Inducer was 
then switched on.  The device is designed to carry out automatic iontophoretic 
stimulation of the local sweat glands by passing a DC current of 1.5 mA between the 
electrodes for a period of 5 minutes, after which the current is automatically switched 
off and a brief alarm signal is sounded.  During stimulation the electric current 
polarises the electrodes and the pilocarpine cation is repelled away from the positive 
(red) electrode and down into the sweat glands, activating their secretion (Figure 2.2). 
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Figure 2.2 The positively polarised red electrode (1) is in contact with the aqueous 
Pilogel® disk (2) containing pilocarpine nitrate (chemical structure also pictured) 
which is partially ionised into positive pilocarpine (Pilo+) and negative NO3- ions.  
The pilocarpine ion Pilo+ (3) is repelled into the skin (4) where it activates the sweat 
glands.  The removal of P+ disturbs the equilibrium leading to further dissociation of 
free Pilo+ ions and the process continues until a steady state is reached.  
 
After iontophoresis the electrodes were removed, the site of iontophoresis cleaned 
once more with distilled water, and a Wescor Macroduct strapped to the circle of skin 
with which the red (+) electrode was in contact, to collect the sweat produced by the 
pilocarpine stimulated sweat glands.  
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After a collection period of approximately 30 minutes the Wescor Macroduct was 
removed, dismantled and the sweat sample expunged into a vial.  This was done using 
a small forceps and a syringe, provided with the sampling kit.  The forceps was used 
to remove the lid of the Macroduct, exposing the coiled tubing.  The syringe was 
filled with air and inserted into the open end of the coiled tubing at the outer 
circumference of the coil, with which it forms a tight seal.  The tubing was then pulled 
free and uncoiled and could be snipped at its base at the other end where it was 
attached to the centre of the Macroduct, i.e. the point at which the sweat enters the 
device during collection.  One now has a length of capillary tubing containing a 
sample of sweat, with an air-filled syringe at one end; therefore by depressing the 
plunger on the syringe the sweat sample can be forced out of the tubing into an 
appropriate container.  All samples were placed into separate 200 µl, capped vials in 
this way, and stored at 4 ºC until analysis was carried out.  Overall 12 sweat samples 
were obtained from CF-positive patients in the CF clinic of Our Lady’s Hospital for 
Sick Children, Crumlin, Dublin.  A further 13 normal samples were collected from 
non-CF sufferers in Dublin City University.  On average 50 to 75 µl of sweat was 
collected from subjects ranging from 13 to 27 years of age.  
 
Analytical procedure: 
A mixed 1.00 mol l-1 stock standard solution of potassium, sodium and chloride was 
prepared by dissolving 7.456g and 8.499g of KCl and NaNO3, respectively, in water 
and making up to volume in a 100ml volumetric flask.  This was diluted to give 0.02, 
0.04, 0.06, 0.08, 0.1, and 0.12 mol l-1 standard solutions.   
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To facilitate analysis of the samples via the array and the two separate reference 
methods, it was decided necessary to dilute the samples due to the volume constraints 
imposed by the small (<100µl) sample volumes which may be collected via the 
Macroduct.  Two of the CF positive samples were rejected before analysis, as the 
volume of sweat collected was insufficient (<10 µl).  From the remainder of the 
samples approximately 75 µl of neat sweat from each sample was accurately 
transferred to a pre-weighed 2 ml vial and diluted to 500 µl, using 0.1 M magnesium 
acetate to buffer the ionic strength. The sample volumes were accurately transferred 
into the 2 ml vials using a 100 µl Transferpette® and the vials were also weighed 
before and after addition to confirm the sweat sample volume transferred.  In 
preliminary work, lithium acetate was used as a diluent and ionic strength buffer but 
the lithium ion peak was found to be masking the sodium peak in the cation IC 
reference method chromatograms.  Magnesium acetate was tried and the problem was 
remedied.  
 
The 6 standards (0.02, 0.04, 0.06, 0.08, 0.1, and 0.12 mol l-1 standard solutions) were 
diluted by the same dilution factor (and with the same ionic strength buffer). A 
volume of 400 µl of each diluted sample was reserved for analysis via the array.  
Activity coefficients for the ions were calculated according to the Davies equation1 
(Equation 2.1). 
 

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51.0log 2      Equation 2.1 
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The array was conditioned overnight in the 0.1 mol l-1 standard.  Before use, the array 
was flushed with Milli-Q water for several minutes at a flow rate of 2.1 ml min-1.  The 
array was then flushed with each solution for approximately 15 s before measuring 
the response.  During the measurement period, the analyte solution flow rate was 
reduced to 0.1 ml min-1 and the steady state signal measured for approximately 30 s 
after stabilisation had occurred (usually within 1-2 seconds).  The lowest standard 
(0.02 mol l-1 in sodium, potassium and chloride) was used to set the baseline.  Then 
each of the other standards (0.04, 0.06, 0.08, 0.1, and 0.12 mol l-1 in sodium, 
potassium and chloride) were passed through in the same way, with the 0.02 mol l-1 
standard being re-analysed between each standard to investigate the possibility of 
hysteresis or baseline drift.  The sample unknowns were then analysed, with the 0.02 
mol l-1 standard again being re-run between each sample.  When all samples had been 
analysed the calibration regime was repeated, ending as before with the lowest 
standard. 
 
A Gilson Minipuls 3 peristaltic pump connected to the array with microbore capillary 
tubing was used to pump standard and sample solutions through the flow-cell.  
Signals from the sensors were transferred after impedance conversion to a portable 
PC, via a National Instruments Lab-PC 1200 data acquisition card. The digital data 
acquired from each sensor were displayed simultaneously as real time millivolt 
readings on the PC screen, as in the previous study and saved as ASCII text files. 
Microsoft Excel was used for post-acquisition data analysis and for graphical 
representation of the data obtained, as usual. 
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The remaining 100 µl of each diluted sample was reserved for analysis by the 
reference methods. A tenfold dilution with Ultrapure water was carried out to bring 
the volume up to 1 ml. 0.5 ml of this was set aside for ion chromatographic analysis, 
and the remaining 0.5 ml was further diluted volume in 25 ml volumetric flasks for 
AAS analysis.  
 
 
 
2.2.3 Reference Methods 
 
Anion analysis 
Chloride determination for all samples was carried out on a Dionex DX-120 ion 
chromatograph with suppressed conductivity detection.  The analytical column was a 
standard Dionex Ionpac® AS-14, 4mm column with mobile phase 4 mM p-hydroxy-
benzoic acid with 2.5% methanol, adjusted to pH 8.5 with NaOH, at a flowrate of 1 
ml min-1.  The method used was obtained from www.dionex.com. The Ionpac® AS-
14 is a universal column for the fast separation of inorganic anions23.  The stationary 
phase is a surface-functionalized polymer-based ethylvinylbenzene / divinylbenzene 
(EVB / DVB), and p-HBA is a commonly used mobile phase which facilitates single-
column chromatography and direct conductivity detection, as well as suppressed 
conductivity.  
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A note on ion suppression in IC 
Ion suppression is designed to enhance conductivity detection sensitivity in ion 
chromatography4.  Traditional ion chromatography eluants such as NaOH (Anion IC) 
and HCl (Cation IC) are highly dissociating and present a constant high background 
conductivity against which it can be difficult to attribute small conductivity changes 
to eluting analytes.  The situation can be improved through the use of weak organic 
acids, such as hydroxybenzoic acid (HBA), which facilitate single column 
chromatography and direct conductivity detection as they are weakly dissociating and 
therefore have a lower background conductivity.  Nevertheless, suppressors can still 
provide sensitivity with such eluants, and presently ion suppression methods are 
commercially available for most instruments and applications. These suppressor units 
perform post separation neutralization of mobile phase salts to lower the background 
conductivity before entry to the detector.  The units are also now available with self-
regenerating mechanisms, which continuously generate H+ and OH- ions through the 
electrolysis of water (oxidation at the anode to produce H+ ions and reduction at the 
cathode to form OH- ions).  In anion chromatography the suppressor unit has a cation 
exchange membrane, which exchanges eluting mobile phase cations, such as Na+, for 
H+ ions.  Similarly in cation IC, an anion exchange membrane exchanges eluting 
anions for OH-.  The end result is that the analyte ions enter the detector in a water 
solution eluant with greatly reduced background conductivity, while analyte 
conductivity remains high (Figure 2.3). 
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Figure 2.3 Ion chromatography with suppressed conductivity detection. 
 
 
Cation Analysis 
 
 (i) Ion Chromatography 
Cation analysis was carried out using two methods due to equipment constraints.  
Samples 1 to 16 were analysed by AAS (see below) and samples 16 to 23 analysed by 
cation IC.  The IC was again carried out on a Dionex instrument using a CG14 guard 
column and an Ionpac® CS14 analytical column, with a Dionex cation self-
regenerating suppressor (CSRS-II) unit and conductivity detection.  The mobile phase 
was 10mM Methane Sulphonic Acid, at a flowrate of 1 ml min-1. 
 
 
(ii) AAS 
AAS for sodium and potassium determination was carried out on a Perkin Elmer 
Model 3100 atomic absorption spectrometer under the following conditions:  
 
 37 
 
   Sodium    Potassium 
Lamp:      Sodium Hollow Cathode Potassium Hollow Cathode 
Lamp current:    5mA    5mA 
Fuel:      Acetylene   Acetylene  
Support:     Air    Air 
Flame stoichiometry:   Oxidising    Oxidising 
Wavelength:     589.0 nm   766.5 nm 
Slit width:     0.5 nm   0.5 nm 
Working range:    0.002 to 1.0 ppm   0.1 to 2.0 ppm 
 
Calibration curves were constructed for each method and used to estimate sample 
concentrations. 
 
 
 
2.3 Results and discussion 
 
Table 2.1 below shows the mV responses of the electrodes in the array to the 
calibration regimes.  Mean values were calculated and used to construct standard 
calibration curves, shown in Figure 2.4.  These calibrations were carried out at the 
beginning and end of the trial, approximately 30 minutes apart, so some drift is 
expected.  This drift appears to be more pronounced for the chloride electrode than for 
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sodium and potassium. The slopes for the three electrodes are, however, quite 
consistent.   
 
 
Table 2.1 mV responses of the electrodes in the array to the standard calibration 
regimes, carried out before and after sample analysis.   
Standard Electrode
K+before K
+
after Na+before Na+after Cl-before Cl-after
(mV) (mV) (mV) (mV) (mV) (mV)
20 14.0 15.8 -14.0 -16.0 -102.2 -109.0
40 31.0 31.8 1.2 5.2 -119.7 -123.7
60 41.5 42.0 11.4 14.0 -130.5 -134.9
80 48.6 49.0 18.7 19.9 -137.4 -142.4
100 54.8 54.8 24.2 25.0 -142.5 -148.5
120 59.2 59.6 29.1 29.7 -147.0 -153.0
Slope 60.48 58.39 57.60 59.59 -59.89 -59.45
(mV/dec)
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Figure 2.4 Standard curves from the 3 sensors.  The responses are linear over the 
desired range, and Nernstian slopes are observed for the three electrodes.  
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   Electrode
Sample         K+            Na+      Cl-
response activity response activity response activity
(mV) (mol/L) (mV) (mol/L) (mV) (mol/L)
1 17.10 0.018 19.35 0.063 -113.61 0.023
2 21.12 0.021 19.00 0.062 -115.49 0.025
3 25.28 0.025 18.90 0.062 -126.49 0.038
4 -3.12 0.008 -0.32 0.029 -91.92 0.010
5 3.04 0.011 5.84 0.037 -98.50 0.013
6 21.40 0.022 9.12 0.042 -126.76 0.038
7 13.01 0.016 -7.52 0.022 -117.24 0.027
10 14.56 0.017 -0.87 0.029 -107.77 0.018
11 15.29 0.017 12.16 0.048 -109.72 0.020
12 2.96 0.011 -17.06 0.015 -91.19 0.010
13 -4.59 0.008 -10.73 0.019 -82.87 0.007
14 13.18 0.016 -18.42 0.014 -102.78 0.015
15 -4.26 0.008 -0.50 0.029 -84.57 0.008
16 -12.81 0.006 -9.74 0.020 -77.68 0.006
17 10.08 0.014 24.91 0.079 -106.26 0.017
18 20.63 0.021 17.05 0.058 -108.48 0.019
19 14.04 0.016 21.83 0.070 -113.75 0.023
20 12.30 0.015 20.39 0.066 -116.07 0.025
21 14.38 0.017 20.40 0.066 -116.89 0.026
22 1.37 0.010 5.80 0.037 -93.27 0.011
23 -3.19 0.008 -3.04 0.026 -90.10 0.009
 
Table 2.2 This table lists the mV responses to each sample for each electrode and the 
ion activities estimated from the standard curves.  Sample volume was insufficient to 
allow duplicate analysis for calculation of standard deviations.  The mV values do 
however represent a mean response over a 30 second monitoring period.  The red 
colour indicates samples taken from the CF population, and the green represents 
samples taken from the normal population. 
 
The sample ion activities in Table 2.2 were calculated from the sample millivolt 
responses (also listed in Table 2.2), and the standard curve trend-line equations for 
each electrode (Figure 2.4).   
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Example calculation:  Sample #1, sodium ion. 
The equation of the line from the sodium electrode calibration curve is: 
 
y = 58.6x + 137.9  
 
where “y” is the millivolt response of the electrode and “x” is the logarithm of the ion 
activity.   
 
The mV response of the sodium electrode to sample #1 was 19.35 mV, and this value 
is substituted for “y” in the equation of the line:  
 
x = Antilog [(19.35 – 137.9) / 58.6]  =  0.00949 M   
 
The 6.67 dilution factor must also be taken into account (75 ul in 500 ul): 
 (0.00949)(6.67)  = 0.063 M 
=  sample #1 sodium ion activity 
 
To facilitate direct comparison of the array and reference method results, it was 
necessary to convert activity values obtained from the array, to actual concentrations.  
In anticipation of this, as outlined in the procedure, magnesium acetate was added to 
all standards and samples before analysis to buffer the ionic strength.  For the 6 
standards, the ionic strength “I” was calculated to range from 0.346 to 0.376, and the 
corresponding monovalent ion activity coefficients “fi“, calculated from the Davies 
equation (Equation 1), ranged from 0.687 to 0.683 respectively.  The added 
magnesium acetate was assumed to also be the dominating contributor to ionic 
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strength in the samples.  This is a reasonable assumption because of the expected 
similarity in ionic composition of the samples to the standards.  Table 2.3 shows that 
the CF marker ions sodium and chloride are by far the most prevalent ions in sweat, 
and they are present within the range of the standard calibration.  Samples were 
buffered in the same manner as the standards therefore it should be reasonable to 
assume the total ionic composition of the samples to be sufficiently similar to that of 
the standards to apply the same estimated activity coefficients to the sample 
calculations. 
 
 
 Ion   Sweat Concentration (mM) 
 Sodium    20 to 80 
 Potassium       4 to 18 
 Calcium       0 to 1 
 Magnesium      < 0.2 
 Chloride    20 to 60 
 Bicarbonate      0 to 35 
 Phosphate    0.1 to 0.2 
 Sulphate    0.1 to 2.0    
 _________________________________________                          
Table 2.3 Principal ionic composition of sweat5.  
 
Converting activity to concentration: 
(0.063) / (0.685) =  0.092 M   
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= Estimated sodium ion concentration for 
sample #1 
 
Ion activities were similarly estimated for all samples and converted to concentration 
values.  The results are tabulated in Table 2.4. 
 
   Electrode
Sample K+ (mM) Na+ (mM) Cl- (mM)
1 26.85 92.44 33.81
2 31.38 91.18 36.35
3 36.88 90.84 55.58
4 12.24 42.69 14.64
5 15.55 54.37 18.87
6 31.72 61.86 56.15
7 22.91 32.16 38.89
10 24.33 41.77 26.98
11 25.03 69.69 29.10
12 15.50 22.10 14.23
13 11.56 28.35 10.32
14 23.05 20.95 22.26
15 11.71 42.39 11.02
16 8.40 29.47 8.45
17 20.44 115.03 25.46
18 30.79 84.46 27.73
19 23.83 101.91 33.99
20 22.28 96.32 37.17
21 24.16 96.35 38.37
22 14.57 54.29 15.42
23 12.21 38.35 13.65
 
Table 2.4 Estimated concentration values for the three ions in each sample.  The 
values are listed as mM concentrations.  Once again, the sample numbers’ colouration 
indicates the source population of the sample.  Red is for the CF population and green 
for normal   
 
The analytical performance of the array will be compared later by assessing these 
array results against the results obtained for the same samples via the reference 
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analytical techniques.  For the moment, however, these results will be discussed in 
isolation and in assessed in terms of their diagnostic significance.  
 
The marker ions for CF are sodium and chloride.  The generally accepted diagnostic 
thresholds are 50mM sodium and 60mM chloride, above which is considered 
positively diagnostic of CF6.  These values are, however, only valid for children.  
Sweating rates increase with maturity, which means that there is less time for 
reabsorption of ions in the sweat glands of healthy adults; therefore the sweat ion 
concentrations are higher.  It is now accepted that due to increased sweating rates in 
adulthood, the threshold values used for children are not applicable to adults7.  A 
higher threshold for both marker ions of 80 mM is recommended therefore to separate 
normal and CF adults8,9.  In this study, all of the normal samples were taken from an 
adult population.  For the normal samples therefore; a sodium and or chloride 
concentration of ≥80 mM should be considered diagnostic of CF.  The CF population 
samples were taken from pre-pubescent children, and the Gibson and Cooke 
thresholds of ≥50 mM sodium and ≥60 mM chloride remain relevant. 
 
Applying these diagnostic thresholds to the array results for sodium and chloride in 
Table 2.4, the results for sodium appear to be very good, while the chloride results do 
not.  The sodium results correctly classify all samples in terms of the population from 
whence they came.  The chloride results, however, are all lower than expected.  Both 
the normal and CF chloride values are far lower than expected and in terms of the 
usual thresholds, provide no useful diagnostic information.  The fact that all of the 
chloride values, both CF and normal, are depressed, seems to suggest a chemical 
interference on the chloride electrode, or some other phenomenon, masking the 
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chloride ion concentration.  If the depression is general and not sample- or population- 
specific, then the expected separation of CF and normal samples should still be 
apparent.  To investigate this separation, the sample values were projected onto their 
respective calibration curves, as shown in Figure 2.5, Figure 2.6 and Figure 2.7.  
 
Figure 2.5 This illustrates the degree of separation exhibited by the potassium 
electrode on the CF positive and normal samples.   
 
In Figure 2.5, the black line is the standard calibration curve.  The green circles 
represent the potassium ion activities measured for the normal samples, and the red 
squares represent the CF samples.  Potassium is not a marker ion for CF, so there is a 
certain amount of overlap, but there appears also to be a good degree of separation of 
the two sample populations.  The CF samples are clustered in the upper half of the 
curve and 8 out of 13 of the normal samples are well separated from the CF ones.  
Potassium may provide some complementary diagnostic info therefore as part of a 
total array response. 
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Figure 2.6 This illustrates the degree of separation exhibited by the sodium electrode.   
 
Figure 2.6 clearly shows that the separation is much better for the sodium results.  
There is no overlap of positive and negative sample populations.  The CF samples, 
indicated by the red squares are all tightly clustered together.  The normal samples are 
more spread out but, as seen in Table 2.4, the normal values all fall below the 80mM 
threshold (log aNa+ = -2.09), so they are all firmly diagnosed as negative, and the CF 
samples are all above the threshold.  The sodium electrode therefore exhibits 100% 
diagnostic success for both the CF population and the normal population samples. 
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Figure 2.7 Here we see the degree of separation achieved on the chloride results 
alone.   
 
As seen in Table 2.4, the chloride responses, illustrated graphically in Figure 2.7, are 
all considerably lower than the expected normal and usual CF values.  Traditionally, 
chloride is considered the better diagnostic indicator because of the usually high 
degree of separation between positive and negative samples.  Normal samples are 
usually expected to have a chloride concentration of less than 40 mM (log aCl- = -
2.39), and CF samples are expected to exceed 80 mM.  The data here shows a 
disappointing degree of overlap between the CF and normal samples.  There is still, 
however, quite a degree of separation.  9 out of 13 normal samples are not 
overlapping with the CF samples. 
 
Cluster analysis of the array data was carried out with the aid of Dr. Brendan Duffy, 
using Minitab® software and is presented in Figure 2.8.  Based on the array data for 
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the three ions, the samples were divided into two distinct groups.  The CF samples 
were all grouped together and, with the exception of two samples, the normal samples 
were also grouped together.  
 
Figure 2.8 Cluster analysis dendrogram for Na, K and Cl in sweat samples, illustrating 
the separation of the two sample groups. Two of the normal samples (6 and 11) were 
falsely diagnosed as positive. 
 
The reason for this misclassification of the normal samples 6 and 11 can be explained 
by closer examination of Figure 2.5, Figure 2.6 and Figure 2.7 which illustrate the 
degree of discrimination obtained from each of the three sensors, which ultimately 
contributed to the cluster analysis.  Closer examination of these graphs, and indeed of 
Table 2.4 which lists the actual estimated concentrations, also provides an insight into 
the reason for the misclassification of the normal samples 6 and 11.  
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First of all the table and the graphs illustrate why two distinct groups emerge.  In 
broad terms it is possible to say that samples taken from the normal population have 
lower potassium, sodium and chloride levels than samples taken from the CF 
population.  Samples 6 and 11 were taken from a normal population but the cluster 
analysis software has grouped them with the CF population samples.  Therefore 
according to the software, samples 6 and 11 are more closely associated with the CF 
samples than the normal samples.  If one calculates mean and standard deviation 
values for the two populations, the following results are obtained (Table 2.5). 
 
 
          K+         Na+               Cl- 
Mean (stdev)  Mean (stdev)  Mean (stdev)  
CF  27.08 (5.54)  96.07 (9.20)  36.06 (9.09) 
Normal 17.60 (7.01)  41.42 (15.15) 21.54 (13.54) 
Sample 6 31.72   61.86   56.15 
Sample 11 25.03   69.69   29.10    
Table 2.5 Group mean and standard deviation values calculated from the array results. 
Included for comparison are the values obtained for the cluster analysis misclassified 
normal samples, 6 and 11.  
 
From this table one can see again that the population means for all three ions are 
higher for the CF population than the normal population.  One also sees that the 
reason for the misclassification of the two normal samples is because the individual 
concentrations of the three ions are consistently high relative to the group means.  
Sample 6 in particular, though taken from a normal population, has a measured 
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potassium and chloride concentration in excess of the CF group mean.  This is further 
illustrated in Figure 2.5 –samples 6 and 11 are the two highest placed normal samples 
in terms of potassium concentration; in Figure 2.6 which illustrates the sodium ion 
concentrations they are again the highest placed samples of the normal population 
samples; and in Figure 2.7 for chloride, where sample #6 is the highest placed of the 
normal samples and #11 is the third highest placed.  This is what distinguishes the two 
samples 6 and 11 from the rest of the normal population.  From Figure 2.7 sample #7 
seems also to be grouped with the CF samples, but this does not lead to an overall 
misclassification.  This is because the contribution from all three ions is taken into 
account in the cluster analysis, and the sodium ion concentration of sample #7 is low 
and clearly normal, which associates it with the normal population. 
 
In this case, therefore, the use of an array of three sensors is counter-productive in a 
diagnostic sense, because the total array response yields two false positives, whereas 
assessment on the basis of the sodium results alone, yields 100 % diagnostic accuracy.  
 
The poor performance of the chloride electrode was disappointing. Chloride is 
considered a better diagnostic indicator because the elevation in sweat chloride from 
CF is generally greater than that for sodium.  This results in greater separation and 
less borderline diagnostic confusion.  In all previous work involving standards and 
simulated samples the chloride response was as expected.  Sweat is primarily a dilute 
saline solution so it seemed unlikely that some sweat-based component was causing 
the chloride electrode interference.  The apocrine sweat glands, e.g. in the underarms 
release a thicker, yellowish, sweat secretion containing fatty acids and proteins as well 
as the usual electrolytes, but the primary thermoregulatory sweat glands, the eccrine 
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(or merocrine) glands, as found on the forearms and from where sweat was sampled 
in this study, secrete only an aqueous dilute electrolyte solution in which sodium and 
chloride are the primary ions.  The only other constant to affect all samples is the 
pilocarpine nitrate used in the generation of the sweat samples by stimulation of the 
sweat glands.  Anion-sensitive membranes based on organic ammonium ions (such as 
the SendX® chloride electrode, which is based on the ion exchanger 
tridodecylmethylammonium chloride (TDMAC)), follow a selectivity pattern 
described by the Hofmeister series (Table 2.6)10. 
 
 
ClO4- > SCN- > I- > Sal- > NO3- > Br- > Cl- > HCO3- > OAc- > SO42- > HPO42-  
Table 2.6 Hofmeister Series.  Decreasing lipophilicity from left to right 
 
 
The nitrate ion therefore is a potential interferent on the chloride electrode response, 
and sample contamination from the pilocarpine nitrate may be the source of this 
interference.  The SendX® array of course is designed for blood analysis, where 
nitrate interference is not expected.  Fluka selectophore documentation provides 
selectivity coefficients for a similar TDMAC based solvent polymeric membrane 
cocktail for chloride activity determination in whole blood and serum.  A Pot NOClLogK −− 3,  
= 0.56 is quoted11 (mixed solution method at 115 mM NaCl, 5 mM KOAc, 35 mM 
NaOAc) which suggests an electrode nitrate response that is 3 to 4 times greater than 
its response to chloride.  The expected concentration chloride in blood is ca 115 mM, 
nitrate is not a major component of blood; therefore this preferential response to 
nitrate would not pose a problem in blood analysis.  However, in this study nitrate 
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interference is an issue.  A series of simple experiments were carried out therefore to 
investigate the effect of the nitrate ion on the SENDX(R) chloride electrode, and also 
to investigate the effect of the pilocarpine nitrate contained in the pilogel disks to the 
chloride response of the electrode.  
 
In the first experiment, 3 standards solutions containing 40 mM, 50 mM and 60 mM 
NaCl respectively, were passed through the array, followed by a fourth solution that 
was 50 mM in NaCl and 50 mM in KNO3. The real-time analytical trace is shown in 
Figure 2.9. 
 
 
Figure 2.9 Analytical trace showing the mV response of the chloride electrode to the 
series of solutions as illustrated.  Data capture was paused during solution 
changeover. Clearly the electrode is responding normally to the increasing chloride 
concentration, and then there is a huge change in the electrode response to the 
presence of similar concentrations of nitrate ion.  The 50 mM NaCl solutions with and 
without nitrate present were re-analysed to illustrate the reproducibility of the nitrate 
response.  
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The chloride electrode clearly responds very strongly to the presence of nitrate. In a 
second experiment, three more NaCl standard solutions were made up that were 40, 
60 and 80 mM in NaCl.  Into the 60 mM standard was placed a fresh pilogel disc, 
which had been ground to a paste using a pestle and mortar. The mixture was 
sonicated for 5 minutes and then filtered. The 40 mM NaCl standard was passed 
thorough the array in the usual fashion, followed by the 80 mM standard, and then the 
filtrated solution from the 60 mM standard sonicated with the pilogel disc.  The 
analytical trace is shown in Figure 2.10 
 
 
Figure 2.10 The trace shows the response of the chloride electrode to 40 mM and 80 
mM standard solutions of NaCl, and then its response to a 60 mM standard after 
sonication with a pilogel disc (0.5% pilocarpine nitrate) 
 
The trace clearly shows a large response to the pilogel infused sample, which may be 
attributed to nitrate from the disc.  These experiments seem to suggest that the nitrate 
ion, which is the pilocarpine counter-ion present in the pilogel disc formulation, may 
indeed be the cause of the chloride electrode interference.  Pilocarpine iontophoresis 
is the standard method of sweat stimulation and is unlikely to change; therefore the 
 54 
investigation of other chloride electrode formulations that are less susceptible to 
interference from nitrate ion, or the use of other pilocarpine formulations where 
nitrate is not the counter-ion, are pointers for the future.   
  
 
Reference methods 
 
As described earlier, ion chromatography (IC) and atomic absorption spectroscopy 
(AAS) were used as reference methods to compare to the sample concentrations 
calculated from the array data.  The calibration curves obtained from these two 
reference methods for each of the ions under investigation are illustrated below in 
Figure 2.11 to Figure 2.15.  These calibration curves were also used to calculate 
sample concentrations and the results obtained by the two reference methods were 
tabulated alongside the results from the array for comparison purposes – see Table 2.7 
 
Figure 2.11 AAS Calibration curve for potassium 
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Figure 2.12 AAS Calibration Curve for Sodium 
 
 
Figure 2.13 IC calibration curve for potassium 
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Figure 2.14 IC calibration curve for sodium 
 
 
 
Figure 2.15 IC calibration curve for chloride 
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Table 2.7 Comparison of the estimated concentrations calculated from the array data, 
with the “true” concentrations calculated from the reference methods’ data.  For each 
ion the array value and reference value is listed, along with the reference method used 
to analyse the sample, and the absolute error is also quoted.  As before, the coloration 
indicates the population from the sample was taken – red for CF and green for normal.  
The population means and standard deviations as well as the mean error values were 
also calculated and listed in the lower half of the table at the foot of each column of 
data.  Five of the samples (10 & 13-16) could not be analysed for chloride by any 
reference method due to instrumental difficulties. 
 
Table 2.7 compares the array results with the reference methods used.  For diagnosis, 
a sodium concentration greater than or equal to 80 mM is considered a positive 
indication of CF.  All of the CF samples are above and all of the normal samples fall 
     K+          Na+         Cl-
Array Ref.  Error Array Ref. Error Array Ref Error
(mM) (mM)  (abs) (mM) (mM) (abs) (mM) (mM) (abs)
1 26.85 24.14 (AAS) 2.71 92.44 95.10 (AAS) -2.66 33.81 101.62 (IC) -67.81
2 31.38 28.96 (AAS) 2.42 91.18 93.43 (AAS) -2.25 36.35 78.32 (IC) -41.97
3 36.88 36.21 (AAS) 0.68 90.84 95.14 (AAS) -4.30 55.58 90.47 (IC) -34.89
4 12.24 12.07 (AAS) 0.17 42.69 40.11 (AAS) 2.58 14.64 15.58 (IC) -0.95
5 15.55 14.48 (AAS) 1.07 54.37 43.49 (AAS) 10.88 18.87 2.17 (IC) 16.71
6 31.72 28.96 (AAS) 2.76 61.86 61.72 (AAS) 0.14 56.15 12.27 (IC) 43.88
7 22.91 24.14 (AAS) -1.23 32.16 36.77 (AAS) -4.60 38.89 18.26 (IC) 20.64
10 24.33 16.90 (AAS) 7.43 41.77 43.30 (AAS) -1.53 26.98 - (IC) -
11 25.03 19.31 (AAS) 5.72 69.69 65.20 (AAS) 4.49 29.10 23.32 (IC) 5.77
12 15.50 14.48 (AAS) 1.02 22.10 21.75 (AAS) 0.35 14.23 43.21 (IC) -28.97
13 11.56 12.07 (AAS) -0.51 28.35 28.40 (AAS) -0.05 10.32 - (IC) -
14 23.05 19.31 (AAS) 3.74 20.95 20.10 (AAS) 0.85 22.26 - (IC) -
15 11.71 7.24 (AAS) 4.47 42.39 48.34 (AAS) -5.95 11.02 - (IC) -
16 8.40 9.65 (AAS) -1.25 29.47 31.78 (AAS) -2.31 8.45 - (IC) -
17 20.44 19.92 (IC) 0.52 115.03 128.22 (IC) -13.19 25.46 97.59 (IC) -72.12
18 30.79 26.80 (IC) 3.99 84.46 83.41 (IC) 1.05 27.73 85.68 (IC) -57.95
19 23.83 22.90 (IC) 0.94 101.91 95.11 (IC) 6.80 33.99 112.53 (IC) -78.53
20 22.28 19.99 (IC) 2.29 96.32 98.00 (IC) -1.68 37.17 117.30 (IC) -80.13
21 24.16 19.27 (IC) 4.88 96.35 93.33 (IC) 3.02 38.37 88.54 (IC) -50.17
22 14.57 15.15 (IC) -0.58 54.29 55.90 (IC) -1.61 15.42 30.04 (IC) -14.62
23 12.21 12.79 (IC) -0.58 38.35 40.15 (IC) -1.80 13.65 33.47 (IC) -19.83
mean 27.08 24.77 1.94 96.07 97.72 -0.56 36.06 96.50 -28.81
stdev 5.54 5.77 9.20 13.06 9.09 13.44
Mean 17.60 15.89 41.42 41.31 21.54 22.29
stdev 7.01 5.92 15.15 14.06 13.54 13.04
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below this threshold for both the array and the reference methods.  Diagnostic 
accuracy is therefore 100% and diagnostic agreement between the array and the 
reference methods is also 100 %.  The analytical accuracy of the sodium electrode 
appears also to be acceptable with, in general, excellent agreement between the 
calculated array sodium concentrations and the “true” reference values (mean absolute 
error of -0.56 mM).  
 
The chloride diagnostic threshold is 60 mM, above which is suggestive of CF.  From 
the reference (IC) data we can see that, diagnostically, 100% accuracy is again 
achieved and we can see the magnitude of the separation between normal and CF 
samples.  All of the CF samples show a chloride concentration of over 80 mM and all 
of the normal samples are below 50 mM.  The population means also show that the 
separation for chloride is greater than for sodium.  Unfortunately, the apparent 
pilocarpine nitrate interference on the chloride electrode means that the quality of the 
chloride data from the array is poor and the agreement between the array and 
reference results is poor.  
 
Besides this, however, the array results for potassium appear to be in good agreement 
with the reference methods.  Although potassium is not a diagnostic indicator for CF, 
from the population mean values, CF-related elevation in sodium and chloride levels 
appears to be accompanied by a general increase above normal of potassium 
concentration.  Potassium levels therefore may provide useful information in terms of 
an overall array response, or as an internal marker to confirm diagnosis.  
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2.4 Conclusions 
 
Overall the results obtained were very encouraging.  The SendX® device was purpose 
designed and built for a very specific and very different application, i.e. whole blood 
analysis, but it was adapted here for the diagnosis of CF, with some degree of success.  
A custom designed unit could incorporate a number of platform improvements to 
address the compromises inherent in the use of a device not specifically designed for 
the application: the size of the array and subsequent dead volume, required dilution of 
the sweat samples; the fact that most of the sensors in the array are superfluous for 
this application.  The interference exhibited by the chloride electrode is also problem 
for this application, but not in blood analysis of chloride levels as blood should 
certainly not contain appreciable levels of nitrates.  The sodium and potassium 
electrodes performed much better, with excellent accuracy exhibited by both sensors, 
diagnostically and analytically, comparing well with much more sophisticated, much 
more expensive bench top instruments such as AAS and IC.  Also the ability of a 
miniature array, such as this, to analyse multiple ions at once with similar levels of 
accuracy to the 2 larger instruments, is impressive.  Overall (with the exception of 
chloride) the errors are small, given the differences in the two methods.  Clearly, the 
array approach offers comparable results in a much more compact, portable 
instrument.  It was not possible to run replicates owing to the small volume of the 
samples gathered, but the precision of the method is evident from the quality of the 
data.  
 
Portable instruments capable of rapid multi-component analysis can be produced by 
coupling sensor arrays to portable PCs fitted with data acquisition cards.  This 
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configuration, in conjunction with the Labview software development environment 
enables portable analytical instruments to be rapidly customised for particular 
applications.  This approach has been employed for the rapid diagnosis of cystic 
fibrosis with an encouraging degree of success, despite interference by nitrate on the 
chloride electrode response.  The integration of the sampling and measurement 
process into a single miniaturised unit that can be used at point-of-need is desirable.  
The lifetime of the devices is excellent.  For example, the array used in this was still 
functioning after approximately 3 months of regular use, with no noticeable decrease 
in performance.  The coupling of such portable sensor-based analytical instruments 
with rapidly developing wireless (rf or Bluetooth®) communications technologies 
presents the exciting prospect of much more compact autonomous sensing systems, 
which are capable of making sophisticated analytical measurements for extended 
periods of time at point-of-need without human intervention12. 
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3 CF Watch  
 
3.1 Introduction 
 
This chapter follows the steps taken in the development of a wearable, watch-type 
device for the rapid on-line diagnosis of Cystic Fibrosis (CF).  It was to be based on 
the standard, and universally accepted Gibson and Cooke sweat test1, which has been 
in existence since the 1960’s and is still regarded as the gold standard test for CF as 
well as being one of the most reliable tests in modern medicine2.  The device was 
designed to be compatible with modern, commercially available, and widely used, 
sweat sampling equipment, and the construction of the sensors was based on tried and 
tested formulae to ensure reliability in the finished prototype.  A number of different 
materials were assessed in the construction of the device, and compatibility of 
materials as well as assessment of the devices at various stages of production involved 
a number of surface visualisation techniques from bench-top microscopy to scanning 
electron microscopy.  A test-well was also constructed to facilitate construction and 
testing of the sodium and chloride sensor designs and to assess their performance 
against a standard reference electrode.  
 
Finally a working 2-sensor prototype was constructed consisting of one miniature 
sodium PVC membrane electrode and one Ag/AgCl electrode.  The Ag/AgCl 
electrode takes the place of the usual standard reference electrode, i.e. an electrode 
that would not, by definition, respond to changes in the concentration of the sample.   
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The Ag/AgCl electrode, however, was expected to respond to changes in the chloride 
concentration, but in the opposite “direction” to that of the sodium ISE.  Both 
electrodes therefore would be contributing to the overall cell potential Ecell where: 
 
Ecell = ENa+ - ECl- 
 
It was hoped that this arrangement would provide the optimal discrimination of 
monitoring both of the CF marker ions, while using the minimum number of sensors.  
 
Following testing, a prototype working device was employed in a clinical trial 
involving the analysis of real sweat samples from a confirmed CF population and a 
normal population to assess its usefulness as a possible real-world diagnostic / 
screening device. 
 
  
3.2 Equipment and Reagents 
 
3.2.1 Equipment 
 
Prototype devices were constructed in-house using a CAT3d drilling and milling 
machine.  Membrane and sub-membrane solutions were deposited using WPI glass 
micro-litre syringes compatible with an Ultra Micro Pump II syringe pump and 
micromanipulator also obtained from WPI (World Precision Instruments 
www.wpiinc.com.).  Sub-membrane hydrogel solutions were cured using an ELC403 
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UV-Light Curing Gun manufactured by the Electro-Lite Corporation (43 Miry Brook 
Road, Danbury, CT, USA) and purchased from Edmund Scientific www.edsci.com.  
Visualisation and inspection of devices and of dispensed layers before, during and 
after dispensing and post-curing etc, was carried out using a standard bench top 
microscope with a black and white camera attachment (obtained from WPI), linked to 
a PC to allow microscopic image capture.  Scanning Electron Microscopy was carried 
out using a Hitachi S3200N SEM microscope. 
 
 
3.2.2 Materials and reagents 
 
Substrate plastics (PVC, Perspex, and Polycarbonate) and silver wire (0.5 mm 
diameter) were all obtained from Goodfellow GmBH (www.goodfellow.com).  The 
sodium ionophore (4-tert-Butylcalix[4]arene-tetraacetic acid tetraethyl ester) was 
synthesised and purified in-house by Dr. Kieran Nolan.  Reagent grade (99.8% pure) 
NaCl and AgNO3 were purchased from Fluka.  Acrylamide, TEMED (N,N,N’,N’-
Tetramethylethylenediamine), N’N”-methylene-bis-acrylamide, Glycerin, and (-)-
Riboflavin were all electrophoresis grade and were purchased from Sigma-Aldrich.  
Selectophore® grade Potassium tetrakis(4-chlorophenyl) borate (KTpCIPB), 2-
nitrophenyl octyl ether (2-NPOE), high molecular weight PVC, and cyclohexanone 
were purchased from Fluka.  Sodium hypochlorite (NaOCl, 10-13% active chlorine) 
was purchased from Sigma-Aldrich.  Silver-loaded epoxy was purchased from 
Loctite.  
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Sodium Sub-Membrane Solution  
A salt-doped polyacrylamide hydrogel was utilised as the sodium sub-membrane 
solution.  Hydrogels are polymeric materials with the ability to swell and absorb 
appreciable quantities of water without dissolving and to retain the water within their 
polymeric structure.  They leave no residue, they are repositionable, relatively non-
drying and they make a firm electrical contact3.  They have been used successfully in 
place of internal filling solutions in similar solid-state devices such as are employed 
here4.  Polyacrylamide gels are also used in protein and nucleic acid electrophoresis 
for the separation of macromolecules.  TEMED (N,N,N’,N’-Tetramethyl ethylene-
diamine) is used as an accelerator for free radical polymerisation and N’N”-
methylene-bis-acrylamide is employed as a cross-linking agent.  Glycerol is present as 
a water-soluble hydrating agent, while riboflavin functions as a depolariser in 
membranes5.  The chemical structures of these additives are given in Figure 3.1.  
Ammonium persulphate is often added as an initiator in the production of 
polyacrylamide gels but it was more convenient here to dispense the mixture as an 
unpolymerised solution and to photo-initiate polymerisation in situ using ultra violet 
light (described in Figure 3.2 and Figure 3.3). 
 
1 g of acrylamide monomer, 5 g of 1x10-3 M NaCl (saturated with AgNO3), 15 µl of 
TEMED, 0.2 g of N’N”-methylene-bis-acrylamide, 0.004 g of Riboflavin, and 5 g of 
glycerol were mixed together thoroughly in an aluminium-foil-covered vial.  The 
purpose of the foil was to prevent photo-initiation of polymerisation by ambient light. 
The clear yellow solution was stored at 4 °C until required. 
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Figure 3.1 Sodium submembrane solution components and their structures 
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Sub-membrane hydrogel polymerisation mechanism 
 
 
 
 
 
Figure 3.2 Light sensitive riboflavin molecule interacts with ultra-violet light to form 
riboflavin radicals.  These radicals attack the TEMED molecules, removing a 
hydrogen atom to form a TEMED radical, which initiates the acrylamide 
polymerisation reaction to form long chains of polyacrylamide.  
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Cross-linking  
 
 
Figure 3.3 N’N”-methylene-bis-acrylamide, the cross linking agent, is almost like two 
acrylamide monomer groups stuck together.  It has a reaction-propagating carbon-
carbon double bond at both ends, which serves to link neighbouring chains together as 
they form, as illustrated here.  
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PVC Membrane  
10 mg ionophore and 2 mg ion exchanger (KTpCIPB) were dissolved in 1g plasticiser 
(2-NPOE).  0.5 g of high relative molecular mass PVC was added to produce a slurry.  
3-5 ml of cyclohexanone solvent was then added and the mixture allowed sit 
overnight with stirring to allow complete dissolution.  The resultant clear solution was 
then refrigerated at 4 °C until it was required.  THF was initially used as solvent but 
was found to be problematic during the PVC membrane solution dispensing stage as it 
evaporated too quickly leading to clogging of the microsyringe needles.  
Cyclohexanone, another solvent commonly quoted for the preparation of PVC 
membranes and less volatile than THF, was employed and the problem was resolved 
with no noticeable effect on the performance of the membranes.  
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Figure 3.4 PVC Membrane components and their structures 
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3.3 Watch design 
  
The physical design of the analytical device was to be based around the Wescor 
Macroduct sweat collection system, with which it was to be compatible.  The 
Macroduct, pictured here again in Figure 3.5, is available commercially, and is a very 
simple and reliable method of liquid sweat collection6,7 and has been accepted by the 
scientific and CF community for use as a sweat collection device.   
 
 
 
Figure 3.5 Wescor Macroduct Sweat Collection System (image reproduced from 
www.wescor.com) as used and described previously.  The cut-away shows the 
Wescor device, which is the size and shape of a wristwatch.  The arrow points to a 
small hole in the underneath of the device through which the sweat enters the coiled 
capillary tubing where it is collected.  
 
As seen in Figure 3.5, a capillary hole in the underneath of the Macroduct allows the 
sweat, which has been stimulated by pilocarpine iontophoresis to collect in the coiled 
tubing with minimal evaporation.  In its intended guise the Macroduct therefore is a 
sweat sample collection device.  When the tubing is full, sampling is ceased and the 
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sample is removed from the device for analysis.  Equally however, the same device 
could potentially be used in a sample delivery mode.  By using the length of capillary 
tubing as a sample delivery line to an appropriate flowcell analytical device, and 
utilising the sweat glands as a bio-pump to pump the samples through the flowcell, 
the Macroduct adopts the role of sample collection and delivery. 
 
 
Figure 3.6 Flowchart 1 
 
Figure 3.6 shows a flowchart for the basic analytical procedure followed in the 
previous chapter’s clinical trial using the SendX® array.  It also shows how the CF 
watch device could simplify the procedure.  The 5 basic steps of the original 
procedure and their sequence may be followed via the solid black arrows in the 
flowchart.  The procedure, however, can be short-circuited and simplified 
considerably, as indicated by the dashed red arrow, by bypassing the intermediate 
sample-handling steps between sample collection and sample analysis.  Essentially 
the original procedure requires each sample to be expunged from the length of 
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capillary tubing (in the Macroduct) into which it has been pumped by the sweat 
glands, only for it to be re-injected into another piece of capillary tubing shortly 
afterward and pumped into the sensor array flowcell for analysis.  The reason for this 
is that the Macroduct and the array could not be linked to each other directly because 
they were not compatible due to excessive dead volume demands.  The Macroduct 
allows the collection of up to 75 µl of sweat, but often sample volumes as low as 15µl 
only are collected.  The dead volume of the SendX® array is too large therefore at 
>40 µl.  The SendX® array, however, is a multi-sensor array, and most of the sensors 
in it are redundant for the CF application.  A similar device containing only the 
relevant sensors (sodium and chloride) could therefore be made much smaller, greatly 
reducing the dead volume of the analytical device.  Quite clearly if a device 
compatible with the Macroduct could be used, then it would no longer be necessary to 
remove the samples for dilution, and they could simply be directed into an analytical 
device via the Macroduct capillary line.  And if the device was small and compact 
enough it could be fully integrated into the Macroduct during post iontophoresis sweat 
collection, creating a “CF watch” capable of one-shot sweat sample collection and 
analysis. 
 
The Macroduct devices are sold with a removable transparent plastic cap (not shown) 
that covers and protects the coiled capillary tubing.  This snap-on cover fits into the 
circular central cavity (the white circular central portion seen below in Figure 3.7).  
The fact that the Macroduct was already designed to accommodate a plastic mounting 
was an advantage therefore and the size and fit of this plastic cap was utilised in the 
design of the analytical device.  
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Figure 3.7 Adapted Wescor Macroduct. This is the same basic device pictured in 
Figure 3.5 except the plastic cover has been removed and the capillary tubing 
uncoiled and trimmed back leaving a small section of the tubing.  
 
 
Figure 3.7 shows a dismantled and adapted Wescor Macroduct with the plastic cap 
removed, along with the majority of the coiled tubing.  A short section of the capillary 
tubing is retained for use as a sample delivery line to the analytical device proposed in 
Figure 3.8.  
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Figure 3.8 CAD drawing of proposed design 
 
 
Figure 3.8 shows a CAD drawing of a proposed design for the device.  It consists of a 
plastic disk, small enough to sit on top of the Macroduct, with a flow-through channel 
into which the capillary tubing from the Macroduct delivers the sweat sample as it is 
being collected.  The sweat enters and fills the analytical chamber where it passes 
over a number of sensors before continuing on to waste.  The sensor signals are to be 
taken out from underneath and to the side of the device to facilitate connection to a 
portable PC for on-line monitoring of the sweat as it flows through the device. 
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Figure 3.9 2D top-down and side-on cross-sectional views of the proposed device and 
its dimensions 
 
The dimensions and proportions of the proposed device are shown in the two 
dimensional drawings in Figure 3.9.  The basic size and shape of the device were 
dictated by the Macroduct, on which it must sit.  The flow channels leading to the 
central chamber are designed to accommodate the Macroduct capillary tubing.  The 
side view is a cross section along the central flow-channel.  There is a cavity milled in 
the underneath of the device also, to accommodate the capillary tubing at the centre of 
the Macroduct.  The next figure (Figure 3.10) shows a close-up of the central 
chamber. 
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Figure 3.10 Central flow-chamber and sensor well dimensions. 
 
Figure 3.10 shows a close-up of the central chamber and the sensor wells inside.  0.55 
mm diameter holes were drilled to accommodate 0.5mm silver wire, to be chloridised 
in situ.  The top sensor well is for an Ag/AgCl chloride electrode and the bottom 
sensor well is for a sodium electrode.  The latter has additional layered wells for a 
hydrogel layer and a PVC layer.  The individual sensor construction is described in 
detail later in this chapter.  From the dimensions of the cell, the dead volume of the 
sensor chamber was calculated at 7.2 µl.  
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Figure 3.11 Prototype device based on CAD design to assess its physical size and fit 
to Wescor Macroduct “throne”. 
 
Figure 3.11 shows a sample device milled from the CAD design shown in Figure 3.8, 
mounted onto the adapted Wescor Macroduct as seen in Figure 3.7.  The section of 
capillary tubing, which was retained, fits into the milled flow channel to allow the 
collected sweat sample to proceed into the central analytical, which will house the 
analytical sensors.  One problem, which quickly became apparent with this design, 
was the relative complexity of the shape of the device with respect to the repeated 
milling of small numbers of devices one at a time for the purposes of testing.  For 
each device, as well as milling the flow-channels on the top of the device, milled 
features were also required on the underneath to allow it to fit snugly to the Wescor 
Macroduct. This creates practical difficulties in terms of turning the piece around and 
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repositioning it in the CAT3D machine so that it is properly and accurately lined up to 
continue precision milling on the opposite side.  It also means unnecessary repeat 
milling work for every fresh pair of sensors.  To simplify the procedure, it was 
decided to use an adapter base plate onto which would sit a much simpler device to 
mill, requiring only top-down milling of the flow channels, sample chamber and 
sensor wells.  This would allow the design of a much simpler-to-mill flow through 
cell to house the analytical sensors and speed up the milling process, and the base-
plate would serve as an interface between the flowcell and the Wescor Macroduct.  In 
this way, one base-plate would serve many Macroducts and flow-cell iterations. 
 
 
 
 
Figure 3.12 (a) base-plate and (b) base-plate plus Macroduct.   
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With reference to Figure 3.11 one can see that the base-plate in Figure 3.12 
incorporates all the basic features of the prototype except that a rectangular section 
has been removed, where the flow-channels etc would normally be.  Into this 
hollowed out rectangular section a plain rectangular analytical module (Figure 3.13) 
was fitted.  
 
 
Sample In Sample Out 
Signals Out 
 
Figure 3.13 (a) Analytical 2-sensor flow cell and (b) flow-cell pictured with base-
plate.   
  
The analytical device is a simple rectangular piece, designed to fit the base-plate 
(Figure 3.12a) as shown here in Figure 3.13b.  The flow-channel runs the length of the 
piece from left to right.  In the centre a wider chamber has been milled out to 
accommodate two sensor-wells in which the sensors will be constructed. All that is 
required therefore is milling from one side, of the flow-channel, sample chamber and 
sensor wells.  The picture also shows the silver wires used to take the signals out from 
the two sensors.  Sections of the Macroduct capillary tubing were also used to direct 
the samples into and out of the sample chamber, and short sections of a hypodermic 
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syringe were cut and inserted into the capillary tubing to connect up to the sample 
delivery line in the Macroduct (see Figure 3.7). 
 
 
Figure 3.14 On-line and on-skin sweat analysis.   
 
Figure 3.14 features a sequence of video stills (1 to 7) showing the completed device 
strapped to the arm of an individual who has undergone sweat stimulation by the 
standard pilocarpine iontophoresis method.  The Macroduct fulfils its normal function 
of trapping the sweat produced and channelling it through the capillary hole in the 
back of the device where it enters the capillary tubing.  However, instead of merely 
collecting in the coiled tubing, the adapted Macroduct carries the sweat sample 
through the short section of tubing and on into the analytical device where the sweat 
is passed over the sensors in the central chamber.  The red arrow in still #1 shows the 
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progress and the direction of travel of the sweat sample front.  The sweat sample itself 
is a blue colour and its progress can be easily traced through the rest of the sequence.  
The blue dye is a sample visualisation aid and is a normal feature of the Wescor 
Macroduct – the sweat takes up the blue dye on the underneath of the device as it 
enters the capillary.  The time-line for the sequence is also detailed in Figure 3.14, 
taking approximately 6 minutes for the commencement of sample collection to the 
sample chamber being filled completely.  The video from which these stills were 
taken will be made available on-line as supplementary material at http://doras.dcu.ie. 
 
Figure 3.12 and Figure 3.13 show the piece-by-piece construction of the analytical 
system. One can see the adapter and the manner in which it fits on top of the 
Macroduct to act as a cradle for a simple 2-sensor flow cell.  The wires protruding 
from underneath the device are lengths of 0.5 mm silver wire, used both in the 
construction of the individual sensors and as electrical contact wires to take the 
signals out.  
 
Wescor provide a syringe with their commercial sweat test kits, the cross-sectional 
diameter of which (ca 0.3 mm) is designed to fit neatly into the Macroduct tubing 
forming an airtight seal.  After collecting a sweat sample with the Macroduct, the unit 
is designed to be dismantled by removing the plastic cap, inserting the syringe needle 
into the open end of the capillary tubing and then uncoiling and removing the tubing, 
which is then snipped at the opposite end (the end attached to the plastic disk –the 
point of sample entry).  The sweat can then be expelled into an appropriate vial, using 
the syringe as a pneumatic pump.  Because this syringe needle is designed to provide 
a perfect fit with the Macroduct tubing, short sections of the needle were cut and 
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utilised as connectors to hitch up the sample tubing in the flowcell with that of the 
adapted Macroduct as shown in Figure 3.13 and Figure 3.14. 
 
Figure 3.14 shows the finished device in its intended mode of use.  The images show 
the device strapped to the arm of a “patient” (in this case a willing volunteer from a 
non-CF population) following pilocarpine iontophoresis.  The time-line for the 
sequence from #1 to #7 is approximately 4 minutes 20 seconds.  The entire procedure 
involves pilocarpine iontophoretic stimulation for 5 minutes followed by sample 
collection / analysis for 20 to 30 minutes. The important points illustrated by Figure 
3.14 are that: 
 
(1) The device is sufficiently small to cope with the typical volumes of 
sweat, which the Macroduct is capable of collecting and delivering.  
In its original form as simply a collection device the sample 
volume upper limit was determined by the length of capillary 
tubing inside the Macroduct, which had a maximum dead volume 
of ca 75µl.  After iontophoresis some patients produce <20µl of 
sweat, whereas others may produce several times the volume of 
one Macroduct.  The tubing in the adapted Macroduct used here is 
not used for collection, it is used as a sample delivery line to the 
analytical device.  The sample may be monitored continuously 
therefore as long as sweat is being produced.  The patient’s sweat 
glands, and not the Macroduct therefore now limit the maximum 
sample volume.  Wescor recommend a minimum of 15µl of sweat 
for a valid sample.  As shown in Figure 3.10 the dead volume of 
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the sensor chamber is 7.2µl, i.e. less than half of the minimum 
sample.  Most samples collected will be more than this and are 
generally >50µl.  Compared to the SendX® device dead volume of 
ca 40µl, the new device is clearly more compatible. 
 
(2) The sample is delivered to the analytical sensors in a reasonably 
short space of time.  With reference to Figure 3.14, from the point 
at which the device was strapped to the patients arm after 
iontophoresis to the point where the sweat sample front reaches the 
sensors thereby giving an analytical reading, is ca 5 minutes.  In 
previous trials described in this thesis, and indeed in many CF 
centres worldwide, there is a lapse of a period of days between 
sample collection and sample analysis.  With conductivity meters 
such as those manufactured by Wescor themselves to accompany 
the Macroduct the sample collection period of 30 minutes must first 
be carried out, then the device must be unstrapped, dismantled, the 
capillary tubing removed and a syringe employed to pump the 
sweat sample into the conductivity meter, before a reading can be 
taken.  The time and labour saving seen here is, therefore, a 
significant improvement.  
 
(3) The hydraulic pressure of the sweat glands and capillarity of the 
tube are sufficient to push the sweat sample through the flowcell 
and to fill the analytical chamber to facilitate analysis.  This is 
obvious from the images in Figure 3.14.  
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(4) The dimensions of the flowcell (see Figure 3.10) and in particular 
the construction of the sensor well and the sensors themselves 
exhibit very encouraging flow dynamics.  As the sequence shows 
there are no air gaps, no air bubbles or air traps at any stage in the 
flow system.  This is quite significant as trapped air was 
consistently a major problem with the SendX flow cell.  Air 
bubbles would frequently invade the system through tubing 
junctions and connections and entrap themselves in the concaves 
and convexes of the soft polymer membrane ISE’s.  These air 
bubbles caused large spikes in the analytical signal trace, and were 
often very problematic to remove, requiring high speed flushing 
and agitation of the array, activities which ran the risk of the 
introduction of still more air to the system. 
 
 
This high degree of compatibility with the Macroduct was very encouraging.  The 
next section describes the construction of the device itself and the sensors within. The 
device was then employed in a clinical trial involving the analysis of CF positive and 
negative samples. 
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3.4 Construction of Analytical Device 
 
3.4.1 Choice of Material / Substrate 
 
Three common and easily available plastics were selected as possible substrates from 
which the devices could be made. The primary requirements were: 
 
1. Physical compatibility of substrate with drilling and milling machinery.  
 
2. Chemical compatibility of substrate with membrane components 
 
 
The physical compatibility of the substrate refers mainly to how easy it was to work 
with the material with respect to making small batches of test devices for the purposes 
of this research; however, compatibility with larger scale processes such as injection-
moulding is also an important consideration for the possible future manufacture of 
many devices.  The principal chemical requirement is the quality of adhesion of the 
PVC membrane to the substrate.  The submembrane hydrogel can swell considerably 
exerting not inconsiderable pressure on the cap PVC membrane leading to 
delamination of the membrane and sensor failure if the adhesion is poor8 (see Figure 
3.15). 
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Figure 3.15 Examples of the effect of hydrogel swelling, taken from SEM swelling 
study on solid-state PVC-membrane ISEs in a SendX array, such as was used in this 
research (earlier in this thesis).  (a) A newly made unconditioned sodium membrane; 
(b) a sodium membrane left to hydrate for one day; and (c) after eleven days 
hydration.  The hydrogel swells to accommodate the water molecules, which exerts an 
upward pressure on the cap membrane, which can occasionally lead to rupture of the 
membrane itself8 (d). 
 
 
Three common and easily available plastics were selected for testing:  Perspex, PVC 
and Polycarbonate.  Test devices based on the CAD design in Figure 3.8 were milled 
from each of the substrates to assess the physical attributes of the materials as shown 
in Figure 3.16.  
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Figure 3.16 The three test substrates: (a) Perspex, (b) PVC and (c) Polycarbonate 
 
 
From the test milling, it was possible to mill devices from all three materials (see 
Figure 3.16).  Initially, Perspex and polycarbonate posed a problem for the CAT3d 
milling machine as the heat generated by the cutting tools during high spindle speed 
operation caused the substrates to melt and to fuse to the tool.  These problems were 
overcome, however, by decreasing the spindle speed and increasing the feed rate, 
which can be done through the XCAD software package used to control the CAT3d 
machine.  The CAT3d also has a tool-cooling feature, which pumps a continuous flow 
of coolant (such as water) over the tool during operation.  This is generally intended 
for use when milling much harder materials such as metals, when slow feed rates and 
high spindle speeds and consequently high heat generation are the order of the day.  
This facility was not required here.  
 
All of the materials required a certain amount of post-milling clean up under a 
microscope with a sharp blade to remove “crusts” or “lips” from milled edges.  
Perspex was found to be the most problematic in this regard, followed by PVC, with 
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polycarbonate being the easiest substrate to mill cleanly and with a good quality 
finish.  
 
Basic adhesion testing was carried out by dispensing micro-litre quantities of the PVC 
membrane solution onto 5 cm square pieces of each substrate and leaving overnight to 
dry.  These were inspected the following day and a simple “lift-off” adhesion test 
carried out using a thin, sharp scalpel-type flat blade (Figure 3. 17).  The substrates 
were then immersed in an aqueous 0.1M NaCl solution overnight and re-inspected in 
a similar manner the following day.   
 
 
 
Figure 3. 17 PVC membrane lifting off Perspex surface using a flat blade 
 
 
Post immersion examination of substrates eliminated Perspex, which showed little or 
no adhesion under the conditions investigated.  The deposited membrane peeled off 
with little encouragement required as shown in Figure 3. 17.  This ease of removal 
was not exhibited by the remaining two substrates, which both exhibited strong 
adhesion to the PVC membrane.  On visual examination the deposited membrane 
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solution on the PVC substrate appeared to have been absorbed rather than adsorbed 
by the PVC, whereas in the case of the polycarbonate substrate the adhesion of the 
membrane seemed very strong while still retaining its shape and autonomy as a 
discernable cap membrane.  The polycarbonate was selected for a number of practical 
reasons:   
 
(1) The polycarbonate was easier to mill. 
 
(2) The transparent nature of the polycarbonate substrate greater facilitated the 
development of the device through easy visualisation of milled features, 
dispensed layers and electrical contacts, at all levels of manufacture and 
testing compared to the opaque PVC substrate.  
 
(3) Polycarbonate is very suited to injection moulding, a useful process for the 
batch analysis (and indeed mass production) of many devices and available 
in-house to the research group.  Injection moulding of PVC requires 
special safety considerations because of the dangers of liberation of toxic 
HCl gas at temperatures over 230 °C. 
 
 
For these physicochemical and practical reasons, polycarbonate was considered to be 
the most suitable of the three materials investigated.  In its subsequent use, no 
adhesion difficulties arose and delamination of PVC layers was therefore not an issue. 
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3.5 Watch Sensors 
 
The marker ions for cystic fibrosis are sodium and chloride and it is generally 
recommended that both ions be monitored for optimum reliability9.  It was desirable 
in this case to keep the sample chamber as small as possible to allow efficient analysis 
of the small volumes of sweat  (≤ 15 µl) generally collected via the Macroduct.  The 
sample chamber is potentially the biggest contributor to the dead volume of the 
device, therefore it needed to be kept as small as possible.  This was done by keeping 
the individual sensors themselves small, and by minimising the number of sensors.  
Fewer sensors also make for a simpler device, which is desirable in terms of 
manufacture and ease of use as a potential one-shot screening device.  The possibility 
of using a simple 2-electrode system was therefore investigated, whereby a solid-state 
sodium-ISE would be referenced against an Ag/AgCl electrode, which would act as 
both a pseudo-reference and a chloride electrode. 
 
 
3.6 Electrode manufacture and testing 
 
This section details the construction of the sodium solid-state PVC membrane ISE and 
the Ag/AgCl electrode within the sensor wells.  
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3.6.1 Milling of the flow-cell 
 
 
Figure 3.18 Flow-cell sample chamber and empty sensor wells.   
 
The two photographic images in Figure 3.18 were taken using a microscope with a 
camera attachment, connected to a PC to allow on-screen visualisation and screen 
capture of microscopic images.  They show the central chamber from the top down 
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and at a slight angle.  The schematic below the photographs is of the sample wells and 
helps to explain the photograph images.  The central chamber (as described earlier in 
Figure 3.9 and Figure 3.10) is 2 mm by 3 mm and it is 1.2 mm deep.  The images 
show the sample flow channels leading to and from the chamber.  Inside in the 
chamber are two sample wells.  The one on the left is designed to accommodate a 
silver-silver chloride electrode.  The one on the right is for the sodium electrode 
construction.  It has a similar hole drilled for an Ag/AgCl internal reference electrode, 
there is a larger well to accommodate a hydrogel layer, which acts as the internal 
filling solution, and finally an additional well for the PVC sensing layer.  The 
construction of these sensors is described in detail further on in Figure 3.19 to Figure 
3.23.   
 
The structural features of the flow-cell and sample chamber shown in Figure 3.18 
were milled into the surface of the polycarbonate substrate using a CAT3d milling 
and drilling machine.  The controlling software for this machine is an MS-DOS-based 
package, which requires each movement of the tool and spindle to be inputted 
manually prior to each movement’s execution.  For lengthy and repeat procedures it is 
also possible to pre-program the step-by-step movements of the cutting tool prior to 
execution of the entire sequence of instructions.  In this case, relatively few 
commands were involved, but a number of tool changes were required, which proved 
to be more reliable if carried out manually.  The machine command sequence was as 
follows: 
 
(1) After basic machine, tool, and substrate set-up, a channel was milled (22 mm 
x 1.2 mm x 1.2 mm) (X,Y,Z) using the “Mill Rectangular Cavity From 
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Centre” command and a 1.0 mm (diameter) ball-end milling tool.  These 
channel dimensions were defined by the external diameter of the Macroduct 
tubing (1.2 mm) used to pass the sample in and out of the device, and by the 
total length of the device (20 mm).  The 2 mm overrun was to account for the 
diameter of the tool used and to ensure a thorough cut at either end of the 
channel.  
 
(2) The tool was re-centred and the “Mill Rectangular Cavity From Centre” 
command again used to mill the central sample chamber (3 mm x 2 mm x 1.2 
mm).  An incremental movement instruction (+1 mm in the X direction) was 
performed and the “drill” instruction used to drill a hole 2 mm in diameter and 
1.3 mm in the Z direction, resulting in a cavity 2 mm in diameter, and 100 µm 
deep.  This cavity was intended for the PVC cap membrane.  
 
(3) The tool was exchanged for a 1 mm drill.  This was first used to drill a cavity 
into which the hydrogel would be dispensed.  The “drill” command was again 
used to drill a hole 1.5 mm in diameter and 1.8 mm in the Z direction, 
resulting in a cavity 0.5 mm deep.  The CAT3d has a “spiral” feature, which 
facilitates the drilling of holes larger than the diameter of the drill bit being 
used by spiralling the drill bit to increase the cutting radius. This feature was 
employed here. 
 
(4) The tool was exchanged once more for a 0.5 mm drill bit. The “drill” 
command was used with the “spiral” feature to drill a 0.55 mm diameter hole, 
8 mm deep. This hole was to house the silver wire.  
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(5) The tool was re-centred, moved incrementally –0.5 mm in the X direction, and 
the previous “drill” command recalled to drill another hole for the Ag wire for 
the Ag/AgCl electrode. 
 
(6) The tool was again re-centred and exchanged for a 1 mm cutting tool. To cut 
the finished piece from the polycarbonate substrate the “Mill Square From 
Centre” command was used (20 mm x 10 mm x 8 mm). 
 
Following milling the piece was cleaned and examined under a microscope to remove 
any debris or imperfections.  
 
 
3.6.2 Deposition of Sensing Layers 
 
 
Figure 3.19 Visualisation and dispensing set up.  
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Figure 3.19 shows the equipment used for visualisation and dispensing of sensing 
layers.  The image on the left shows the bench-top microscope and a 50µl glass 
syringe held in a motorised WPI Ultra Micro Pump, which is in turn clamped into a 
WPI Micro-Manipulator.  The Micro-Manipulator allows precise motorised or 
manually controlled micrometer movement of the syringe needle tip, in the X, Y and 
Z directions, with a Vernier scale for each vector.  Not pictured is a camera 
attachment, which allows image capture of what is being observed through the 
eyepieces from above.  This camera was used to obtain the close-up images of the 
flowcell features and the dispensed layers in Figure 3.18, Figure 3.20, Figure 3.21, 
Figure 3.22, and Figure 3.23. 
 
 
Step 1.  
Sections of 0.5 mm diameter pure silver wire were inserted into the drilled holes from 
the top of the device and pulled through from the back and cut to the appropriate 
length.  A small amount of silver loaded epoxy was used to seal the wire into place at 
the back end of the device.  As shown in the photographs and the accompanying 
graphic image in Figure 3.20, the silver wires were allowed to protrude a certain 
distance, inside the sample well in the case of the sodium sensor to ensure adequate 
contact with the hydrogel, and into the sample chamber in the case of the chloride 
electrode to ensure contact with the sample stream. 
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Figure 3.20 Insertion of Ag wires 
 
 
Step 2 
The silver wires were chloridised in situ by immersing them in Sodium Hypochlorite 
for approximately 40 to 60 minutes.  Visual examination of the electrodes confirms 
the formation of an AgCl layer as shown in Figure 3.21.  Gone is the bright silver 
sheen, replaced by a blackish layer of silver chloride.  
 
 
Figure 3.21 Ag wires after chloridisation by exposure to sodium hypochlorite for 60 
minutes. Visual examination confirms the formation of a blackened layer of silver 
chloride.  
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Step 3 
Using the dispensing set-up in Figure 3.19, the hydrogel cavity was filled with the 
uncured hydrogel solution.  The amount was estimated visually rather than 
volumetrically.  The approximate volume of the cavity is ~0.8 µl.  The solution was 
then cured using the ELC403 UV-Light Curing Gun, for 30 minutes at an intensity of 
80mW/cm2.  Successful curing was confirmed by visual examination, clearly 
illustrated by Figure 3.22 in which can be seen the gelled / rippled surface of the 
cured hydrogel.  
 
 
Figure 3.22 Hydrogel layer after curing 
 
 
Step 4 
The PVC solution described earlier was made up and dispensed in a similar fashion to 
the hydrogel.  In the case of the PVC, however, it was necessary to repeat the 
dispensing procedure a number of times to build up the thickness of the membrane 
and fill the cavity, allowing time for the solvent to evaporate off between each 
dispensing.  As shown in Figure 3.23, the provision of a defined cavity for the PVC 
layer is quite neat and provides a definite and consistent contact area for the PVC and 
the substrate to ensure good quality adhesion and minimise failure of the sensors. 
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Figure 3.23 PVC membrane layer.  
 
 
 
3.6.3 Electrode Test Well 
 
 
Figure 3.24 Electrode Test Well used to test sensor construction and performance 
before prior to their incorporation into finished device design. 
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To facilitate testing of the individual sensors against a standard reference electrode, 
the set up illustrated in Figure 3.24 was constructed.  A cylindrical block of nylon was 
hollowed out and four locking nuts attached to the underneath to allow the attachment 
of a cylindrical base plate, sealed with a rubber O-ring.  This set up allows the 
simultaneous construction and potentiometric investigation of several sensors at once.  
After potentiometric investigation the base-plate containing the sensors can then be 
removed and the sensors visualised using an SEM.  
 
A number of sodium sensors therefore were constructed in the same manner as 
described in steps 1 to 4 earlier.  The construction stages are illustrated in Figure 3.25 
to Figure 3.29.  SEM analysis was also carried out and the completed array was used 
in a series of potentiometric experiments to assess sensor performance. An Ag/AgCl 
electrode was also made up and its response to changing concentrations of chloride 
investigated.  
 
 
 
 
Figure 3.25 
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Figure 3.26 
 
 
Figure 3.27 
 
 
Figure 3.28 
 
Figure 3.29 
 
Figure 3.25 to Figure 3.29 show a sequence of microscopic screen-capture images to 
illustrate the stages of construction of the test bed array of sodium sensors: Empty 
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milled sensor wells (Figure 3.25); Silver wire (Figure 3.26); Chloridisation of Ag wire 
to form AgCl layer (Figure 3.27); Cured hydrogel layer (Figure 3.28); and the PVC 
cap membrane (Figure 3.29).  
 
 
Figure 3.30 SEM images of the empty milled wells (a), and chloridised silver wire 
(b). (SE, 20kV, WD 28.5-29.6, Magnification 60-80).   
 
Comparison of the benchtop microscopic images with those obtained by SEM in 
Figure 3.30, illustrates how the higher magnification SEM images can highlight 
structural faults and details that are invisible to the bench-top microscope.  The milled 
surfaces appear rather crude at these higher magnifications, but they are fit for 
purpose in the development of a prototype.  Once a prototype design was established, 
it was then prudent to use a milling machine such as the CAT3d to manufacture a 
precision mould, from which many devices of high quality could be cast.    
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Figure 3.31 SEM images of cured hydrogel layer. (SE, 20kV, WD 28.5, 
Magnification 50-60). The 100µm deep PVC well is also plainly seen, inside in which 
the PVC membrane will be cast.  
 
As seen earlier in Figure 3.15, Scanning Electron Microscopy can be a very useful 
tool for trouble-shooting failed or non-functioning sensors8.  Errors during the 
manufacturing and dispensing process can result in problems such as: poor quality, 
non-uniform deposition of the PVC membrane layer and structural weaknesses in the 
membrane itself, leading to rupture; or poor adhesion of the PVC membrane layer to 
the substrate leading to de-lamination of the membrane at the edges.  Such 
weaknesses, if present, can be exposed by internal pressure from the sub-membrane 
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hydrogel, which swells in volume as it hydrates, exerting pressure on the membrane 
above it.  Hydrogels have the ability to absorb large amounts of water without 
dissolving.  They have three dimensional cross-linked polymer structures, which 
allow them to swell to accommodate water molecules.  The swelling properties of a 
given hydrogel are influenced by the nature the polymer itself, by the nature of the 
cross-linker molecule used, and by the density of the cross-linking.  Polymers and 
cross-links with more polar groups absorb more water and swell more than those with 
fewer polar groups.  The more polar the polymer network, the more attractive it is to 
water molecules.  Greater polarity also increases the electrostatic repulsion within the 
polymer itself, promoting swelling to increase the distance between neighbouring 
polar groups.  
 
 
Figure 3.32 these are two examples of cross-linker molecules used in the preparation 
of polyacrylamide-based hydrogels. Both molecules have the same reaction-
propagating C=C groups at both ends, and therefore serve the same function, but they 
differ in terms of polarity. Bisacrylamide, the cross linker used in this study, is a more 
polar cross-linker than dimethacrylate.  
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Figure 3.32 shows two different cross-linker molecules capable of cross linking 
chains of polyacrylamide.  Both are tetra-functional cross-linking agents, so classed 
because they can attach to the main polymer chain at four locations.  There is a 
carbon-carbon double bond at both ends of each molecule and attachment can occur at 
any of these four unsaturated carbons.  The equilibrium swelling of acrylamide 
polymers cross-linked with bis acrylamide has been shown to be greater than 
acrylamide polymers cross-linked with dimethacrylate10.  The reason for this is the 
greater polarity of the CO-NH-R groups of bisacrylamide over the CO-OR groups of 
the other cross-linker. Cross linking density also decreases swelling ratio, e.g. if a 
trimethacrylate (hexafunctional) cross-linker is used, it has more cross-linking sites, 
cross linking density will be higher, and the degree of swelling will be decreased11.  
Similarly, using a higher concentration of cross-linker also increases the cross-linking 
site density, there are more links, making the polymer more rigid and less able to 
swell.  The hydrogel preparation and curing recipe used here was obtained from 
SendX and had been previously optimised therefore further swelling studies were not 
carried out.  
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Figure 3.33 SEM images of sensors conditioned in 100 mM NaCl.  
 
Figure 3.33 shows two different sodium sensors from the polycarbonate test bed left 
to condition in 100 mM sodium chloride for a period of time, after which they were 
visualised by SEM.  The graphs show how the mV response of the electrodes changes 
during conditioning as the dry hydrogel gradually becomes more hydrated, and the 
SEM photographs show what the membrane looks like at the end of each conditioning 
period.  Figure 3.33(a) is an extreme example of swelling which illustrates the extent 
to which the sub-membrane solution can sometimes swell through the absorption of 
water, and also the flexible nature of the PVC cap membrane in its ability to distort to 
accommodate this swollen sub-membrane hydrogel.  Figure 3.33(b) is an SEM image 
of a sodium ISE left to condition overnight in 100mM sodium chloride.  At the point 
indicated by the red arrow on graph (b), something has happened to the signal and 
from then on it is extremely noisy.  SEM investigation shows a tear in the surface of 
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the PVC membrane.  This may have resulted from the pressure exerted from 
underneath by the swelling hydrogel, or it may have been punctured by the silver wire 
beneath it.   
 
 
3.7 Potentiometric Experiments  
 
Characterisation of Sodium Sensors 
Four electrodes were made up as described and calibrated by a number of methods.  
Initially calibrations were carried out using a Metrohm® 644 bench-top pH meter, 
which was the simplest method of confirming that the sensors were functioning 
correctly.  A 5-point calibration was carried out from 10-5 M to 10-1 M NaCl using a 
standard calomel electrode as a reference as per the setup illustrated in Figure 3.24.  
The pH meter only allows the monitoring of one electrode at a time so the calibration 
was repeated for each electrode.  The electrodes were each allowed to stabilise for 
about 15 seconds and the response was then monitored for a period of about 30 
seconds during which time the highest and lowest readings were recorded (see Table 
3.1).  The average reading was graphed against the log of the activity of the sodium 
ion. 
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Figure 3.34 Calibration curve for sodium sensor #1 
 
 
 
 
Figure 3.35 Calibration curve for sodium sensor #2 
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Figure 3.36 Calibration curve for sodium sensor #3 
 
 
The three calibration curves in Figure 3.36, Figure 3.35, and Figure 3.36 show three 
of the sensors performing well.  The slopes (53.5mV, 52.1mV and 52.1mV 
respectively), though slightly sub-Nernstian, show good consistency and 
reproducibility, particularly for handmade devices.  Reproducibility could be further 
improved by using more sophisticated and automated manufacturing techniques such 
as would be employed in the large scale production of many devices.  The fourth 
electrode was found to be non-functioning due to PVC membrane rupture (see Figure 
3. 37). 
 
 111 
 
Figure 3. 37 SEM image of a non-functioning sensor with a ruptured PVC cap 
membrane 
 
Subsequent SEM analysis of sensor 4 explains its non-functionality.  As shown in 
Figure 3. 37 the PVC membrane is clearly torn at the outer edge.  SEM facilitates easy 
diagnosis of the problem, but it is rather more difficult to ascertain the reason behind 
it.  It is most likely attributable to a fault in the construction of the sensor to begin 
with. Perhaps a sharp or roughly milled edge affected the surface adhesion of the 
PVC, or the membrane may not have been built up sufficiently during the deposition 
process to withstand the swelling of the hydrogel layer.  In general throughout this 
work the adhesion and structural integrity of the PVC membranes were found to be 
very good and sensor failure was not a serious issue. 
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Solution (M)  sensor 1               sensor 2      sensor 3  
 
0.00001         (-247.8, –248.2)  -248.0      (-237.3, -236.3)  -236.8          (-240.7, -239.9)   -240.3 
0.0001  (-205.5, -205.2)  -205.4      (-198.2, -198.0)  -198.1           (-203.5, -203.5)   -203.5 
0.001  (-148.6, -148.8)  -148.7      (-141.8, -141.2)  -141.5          (-148.1, -148.2)   -148.2 
0.01    (-93.7, -93.8)      -93.8        (-88.7, -88.5)      -88.6            (-92.6, -92.6)       -92.6 
0.1    (-43.2, -43.1)      -43.2        (-37.8, -37.9)      -37.9            (-41.9, -42)          -41.2 
 
Slope   53.52   52.09            52.11 
Intercept  14.76   17.63            12.94 
Table 3.1 Calibration data used to generate the three sodium ISE calibration curves 
(Figure 3.34, Figure 3.35, and Figure 3.36). All values in mV. 
 
Table 3.1 shows the calibration data for the three sensors over the 10-1 M to 10-5 M 
range.  Measurements were made in duplicate and the mean values calculated and 
plotted. The slopes were slightly lower than the expected Nernstian response in each 
case, but the general performance of the electrodes was good, and the responses were 
quite rapid and stable. A similar test calibration was carried out in the CF-relevant 
sodium ion range (20 to 100 mM).  The resultant calibration curves are shown in 
Figure 3.38, Figure 3.39, and Figure 3.40. 
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Figure 3.38 Calibration curve for sodium sensor #1 over CF-relevant range, 20-
100mM. 
 
 
 
Figure 3.39 Calibration curve for sodium sensor #2 over CF-relevant range, 20-
100mM. 
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Figure 3.40 Calibration curve for sensor #3 over CF-relevant range, 20-100mM.  
 
 
Solution (mM) sensor 1  sensor 2  sensor 3  
 
20           -64.0   -64.2   -73.7 
40   -49.1   -48.5   -58.0 
60   -40.2   -39.6   -49.6 
80   -34.4   -34.2   -43.7 
100   -20.1   -26.7   -26.9 
 
Slope   56.2   56.3   57.3 
Intercept  34.4   34.8   26.8 
Table 3.2 Calibration data (in mV) used to generate the three sodium ISE calibration 
curves (Figure 3.38, Figure 3.39, and Figure 3.40) over the CF relevant range of 20-
100mM 
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The test calibrations over the expected sodium CF range yield near Nerstian slopes 
and excellent linearity.  Repeat calibrations carried out on a different day, this time in 
triplicate, assessed the reproducibility of the sensor responses.  
 
 
Figure 3.41 Repeat calibration curve, sodium sensor #1 
 
 
Figure 3.42 Repeat calibration curve, sodium sensor #2 
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Figure 3.43 Repeat calibration curve, sodium sensor #3 
 
Figure 3.41 to Figure 3.43 shows three calibrations carried out once again over a full 
5-point calibration range from 10-5 M to 10-1 M NaCl using a standard calomel 
electrode as a reference.  The electrodes were each allowed to stabilise for about 15 
seconds and the response was then monitored for a period of about 30 seconds during 
which time the highest and lowest readings were recorded (see Table 3.3).  This was 
repeated three times for each electrode.  The average of these three readings was 
graphed against the log of the activity of the sodium ion.  N=3 standard deviations 
were also calculated and are listed in Table 3.3.  From the graphs it can be seen that 
once again the slopes are slightly sub-Nernstian but good linearity over the range is 
observed and the results are consistent. 
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Solution (M)  sensor 1   sensor 2   sensor 3  
 
0.00001         (-252.3, -252.5)  -252.4     (-240.7, -240.9)  -240.8          (-243.1, -243.1)  -243.1 
0.0001  (-210.6, -210.5)  -210.6     (-200.3, -201.1)  -200.7           (-202.1, -202.4)  -202.3 
0.001  (-157.6, -157.7)  -157.7     (-155.2, -155.1)  -155.2          (-149.4, -149.4)  -149.4 
0.01    (-96.1, -96.0)      -96.1       (-93.0, -92.7)      -92.9            (-99.7, -99.8)      -99.8 
0.1    (-49.1, -49.2)      -49.2       (-42.6, -42.7)      -42.7            (-49.7, -49.7)      -49.7 
 
0.00001         (-255.8, -256.1)  -255.9     (-242.1, -241.9)  -242.0           (-251.0, -250.6)  -250.8 
0.0001  (-212.1, -212.1)  -212.1     (-202.1, -201.9)  -202.0            (-208.3, -208.1)  -208.2 
0.001  (-158.3, -158.5)  -158.4     (-145.5, -145.7)  -145.6           (-157.3, -157.2)  -157.3 
0.01  (-102.3, -102.3)  -102.3       (-92.3, -92.3)      -92.3           (-101.0, -101.0)  -101.0 
0.1    (-52.4, -52.5)      -52.5       (-42.6, -42.6)      -42.6             (-51.1, -51.1)      -51.1 
 
0.00001         (-250.6, -250.7)  -250.7     (-239.0, -239.2)  -239.1           (-246.9, -247.0)   -247.0 
0.0001  (-209.6, -209.7)  -209.7     (-199.7, -199.7)  -199.7            (-207.9, -208.1)   -208.0 
0.001  (-158.2, -158.1)  -158.2     (-148.8, -148.9)  -148.9           (-156.8, -156.9)   -156.9 
0.01  (-100.7, -101.7)  -101.2       (-93.1, -92.2)      -93.2           (-101.4, -101.5)   -101.5 
0.1    (-52.2, -52.5)      -52.4       (-43.4, -43.4)      -43.4             (-51.1, -51.2)      -51.2 
  
 Standard deviations (n=3) 
 
 
0.00001          2.70   1.46   3.85 
0.0001   1.24   1.15   3.35 
0.001   0.38   4.86   4.42 
0.01   3.34   0.43   0.88 
0.1   1.88   0.45   0.82 
 
 
Table 3.3 Calibration the data used to generate the calibration curves in Figure 3.41 to 
Figure 3.43. The results are given in the format (1st reading, 2nd reading) average 
reading. Standard deviations n=3 were calculated from the average values from the 
triplicate calibrations and used to construct the error bars as illustrated 
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Having established using the pH meter that the sodium electrodes were functioning 
satisfactorily, further experimentation was simplified by interfacing the electrodes 
with a PC via a National Instruments MIO-16 data acquisition card.  This allowed the 
simultaneous monitoring of all electrodes using an in-house written LabVIEW 
program which also facilitated visualisation of the response trace of the electrodes 
over time, and was the intended data capture and monitoring system for use with the 
CF watch.  
 
 
The Ag/AgCl electrode 
 
The external reference electrode for the cell was to be a simple silver-silver chloride 
electrode.  It was prepared in exactly the same way as the internal Ag/AgCl internal 
reference electrodes incorporated into the sodium ISE’s, i.e. by immersing a length of 
silver wire in sodium hypochlorite solution for 40 to 60 minutes to form a layer of 
silver chloride on its surface.  In the analysis of aqueous sodium chloride solutions 
however, this Ag/AgCl “reference” electrode will be expected to respond to changes 
in the chloride ion concentration as an electrode of the second kind.  To investigate its 
performance as a chloride ISE, this electrode was subjected to the same 5-point 
calibration (10-5 M to 10-1 M NaCl) as the sodium test electrodes, using a standard 
calomel electrode as a reference.   
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Figure 3.44 Calibration curve for Ag/AgCl, 10-5 M to 10-1 M NaCl. 
 
From the Ag/AgCl electrode calibration curve in Figure 3.44 it can be seen that the 
slope of the curve, though slightly sub-Nernstian, is adequate, and is on a par with the 
responses obtained from the sodium electrodes to the same calibration regime.  Table 
3.4 below shows that stability of the response is best in the 10-1 to 10-2 M range, 
which is the concentration range of interest for sweat analysis. 
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Solution (M)  Ag/AgCl avg response Standard Deviation 
0.00001           299.4       1.47 
0.0001     261.3       0.79 
0.001     205.5        0.68 
0.01       141.3          0.99 
0.1         87.1         0.09 
Slope     -55.94  
Intercept    29.08 
 
Table 3.4 Ag/AgCl electrode data, used to generate the calibration curve in Figure 
3.44.   
 
 
Sodium and Chloride ISE Combined Response  
 
 
Figure 3.45 Comparison of both electrodes response to the same calibration, using a 
standard calomel reference electrode. 
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Figure 3.45 compares the response of the Ag/AgCl electrode (see Figure 3.44) and 
sodium sensor #1 (see Figure 3.43).  The electrode responses were monitored using a 
LabVIEW virtual instrument interface and a 5-point calibration (10-1 M to 10-5 M 
NaCl) for each of the two electrodes was carried out, using a standard calomel 
reference electrode.  The test set-up pictured and described in Figure 3.24 was used to 
analyse the standard.  As usual, each horizontal portion of the graph represents the 
mV response (x-axis), measured and recorded automatically every two seconds, over 
a period of time (approximately 3 minutes).  After monitoring the response for this 
period of time, the data monitoring software was paused while the test well was 
emptied and rinsed and an aliquot (ca 10ml) of the next standard pipetted into the 
well.  The trace is not intended to represent a real time flow injection analysis trace 
therefore, and while each horizontal portion does represent a real time response, data 
collation was paused between standards.  The graphs illustrate therefore the relative 
responses of the two electrodes to the same standards, it shows that the responses are 
stable and not excessively noisy or prone to excessive drift, and it illustrates also how 
the chloride response mirrors the sodium response but in an opposite direction.  
Referencing the sodium electrode against this “moving reference” chloride electrode 
has the effect of adding the slopes of the electrodes together to give an overall 
response. This is further illustrated in Figure 3.46.  
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Figure 3.46 Response of the two ISE’s relative to each other.  
 
Figure 3.46 shows the same graph as in Figure 3.45 but with the relative response 
between the two indicator electrodes highlighted by the red dotted arrows. As the 
sodium and chloride concentrations increase from left to right ∆mV increases with 
both electrodes contributing to the overall response. 
 
The 5 point calibration was repeated again but without the external calomel reference 
electrode.  Instead the sodium electrode response was measured with the chloride 
Ag/AgCl electrode acting as the reference electrode.  Only one signal was obtained 
therefore, so there is only one signal trace.  The slope of the response is equal to the 
sum of the slopes of the individual electrodes.  The calibration trace is shown in 
Figure 3.47 
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Figure 3.47 Combined Ecell response where Ecell = Eise – Eref  = ∆mV and the Ag/AgCl 
Chloride electrode is employed as a reference.  
 
Figure 3.45, Figure 3.46 and Figure 3.47 illustrate the magnification of the overall 
signal obtained by referencing the sodium electrode against an Ag/AgCl electrode.  A 
CF diagnosis is given by elevated sodium and chloride concentrations; therefore a 
positive CF sample value will evoke a sodium concentration–related response from 
the sodium electrode in a positive direction (Eise), while the same sample will evoke a 
chloride concentration-related response from the Ag/AgCl electrode in a negative 
direction Eref.  The net measured response Ecell = Eise – Eref will effectively be the sum 
of the responses of the individual electrodes.   
 
Figure 3.47 is a graph of the response obtained when the Ag/AgCl electrode is used in 
place of a standard reference electrode.  There are two electrodes but only one 
response trace, and the slope of the cell as shown is the sum of the slopes of the 
individual electrodes.  In Figure 3.43 the slope of the sodium electrode (#1) is 
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51.1mV, and the chloride electrode slope from Figure 3.44 is –55.9 mV. The overall 
cell response in mV per decade change in activity = 
 
 Ecell   = Eise – Eref  
     = ENa+ – ECl- 
     = 51.1 – (–55.9) 
     = 107.0 mV  
 
When measured separately against an external reference, the sum of the slopes is ca 
107 mV.  When the electrodes were referenced to each other, the combined slope was 
calculated at 104 mV (Figure 3.47 inset). Some variation in the slopes is expected, but 
the overall response, as with the individual responses, is lower than the predicted 
Nernstian response (118mV).  A reasonable level of reproducibility was exhibited by 
the individual electrode slopes considering that the devices are hand made, and it is 
important that this reproducibility should carry through to the combined response. 
 
The results obtained so far suggest that the sensors are operational.  The response is 
satisfactory and reasonably consistent and reproducible.  A “CF Watch” device was 
therefore constructed following the design brief already described (Figure 3.18 to 
Figure 3.23) and using the same dimensions, materials and construction methods as 
were used in the manufacture of the test electrodes.  The device was utilised in the 
analysis of real sweat samples in a simulated clinical screening trial  
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3.8 Clinical Trial 
 
A mixed 1.00 mol l-1 stock standard solution of sodium chloride was prepared by 
dissolving 5.85g of NaCl in water and making up to volume in a 100ml volumetric 
flask.  This was diluted with ultrapure water to give 0.02, 0.04, 0.06, 0.08, and 0.1 
mol l-1 standard solutions (= 20, 40, 60, 80 and 100 mM).  21 sweat samples were 
collected, 15 from a normal population, and 6 from a CF positive population.  
Samples were collected on-site at the following locations: Our Lady’s Hospital 
Crumlin CF clinic; Beaumont Hospital CF clinic; and Dublin City University.  For 
ethical and sensitivity reasons the hospital trials did not involve on-skin collection & 
analysis.  Samples were instead collected on-site by pilocarpine iontophoresis and 
stored at 4˚C until all of the samples were collected and could then be analysed 
together in a laboratory environment.  As well as being more ethically sensitive to the 
patients involved, it enabled a more controlled trial to be carried out in the DCU 
laboratory environment.  The on-line situation was mimicked as closely as possible, 
the sweat samples were analysed un-diluted and untreated and a peristaltic pump was 
used to pump the samples through the flow-cell. 
 
 The compatibility of the Macroduct and the analytical device in an on-line analysis 
situation is demonstrated later in Figure 3.54. 
 
AAS was used as a reference method for sodium as in previous trials. The Mohr 
titration method was used as a reference method for chloride. 
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Mohr Method 
 
The Mohr method is a titrimetric method for the quantitative analysis of chloride by 
silver nitrate titration.  The use of silver nitrate in volumetric analysis depends on the 
fact that silver halides are quantitatively precipitated from solution: 
 
Ag+(aq)   + X-  AgX(s)   X= Cl-, Br-, I- 
 
 
The reaction is self-indicating, as precipitation will cease when all the chloride is 
precipitated.  However this method is slow and the endpoint is difficult to ascertain 
therefore potassium chromate is used as a colour indicator to assist in the 
determination of the endpoint of the titration.  The chromate anion forms a brick red 
precipitate with silver ions: 
 
2AgNO3  + K2CrO4   Ag2CrO4  + 2KNO3 
 
 
Silver nitrate is available in a high state of purity and is suitable as a primary standard.  
If silver nitrate is added to a solution containing Cl- ions and a few drops of potassium 
chromate indicator, silver chloride is selectively precipitated before silver chromate.  
The first trace of excess silver ions reacts with the chromate ions present forming a 
brick red precipitate, which marks the end point of the titration.  The Mohr method 
can only be used in neutral solution because silver chromate is soluble in acid solution 
and silver oxide is precipitated from alkaline solution.  The silver nitrate reacts with 
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chloride ions in a 1:1 stoichiometry.  When all the chloride is spent, the first sign of a 
persistent brick-red colour signals the endpoint of the titration. 
 
(Vol AgNO3) (M AgNO3) / (n)    =    (Vol Cl-) (M Cl-) / (n) 
 
The molar concentration of Cl- therefore  = (VAgNO3).(MAgNO3) / (VCl-) 
 
 
Sample treatment 
 
 At least 50 µl of sweat were collected for each sample.  10 µl of this was extracted 
and diluted up to 1000 µl (1ml) (100 fold dilution) for chloride analysis by micro-
titration against 0.005M Silver Nitrate. 
  
50 µl was extracted from each of these titration samples and diluted up to 5000 µl 
with Ultrapure deionised water for sodium analysis by flame emission AAS (a further 
100 fold dilution).  Total dilution factor is a 1 in 10000, and the same was carried out 
on the standards to bring AAS samples and standards within the appropriate AAS 
linear range (0.002 to 1.0 ppm). 
 
 
Worked example: Taking a 50µl normal sweat sample at a presumed sodium and 
chloride concentration of 40 mM.  10 µl are extracted and diluted to 1 ml.  950 µl is 
set aside for titration, while 50 µl are diluted to 5 ml for AAS analysis.   
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Titration 
(0.04M)/(100) = 0.0004M titration sample 
(0.95).(0.0004) = (VAgNO3).(0.005) 
76 µl AgNO3 are required to neutralise the chloride concentration in the sample.  
 
AAS 
The remaining 50 µl diluted to 5000µl for AAS  
(0.04M)/(10000) = 0.000004M 
(0.000004).(58.5) = 0.000234 g/L  
                             = 0.234 mg/L (ppm) 
 
Titration was carried out using a 1ml micro-burette.  Flame Emission AAS was 
carried out under the following recommended conditions:  
(Lamp current: 5mA;  Fuel: acetylene; Support: air; Flame stoichiometry: oxidising;  
Wavelength: 589.0nm; Slit width: 0.5 nm; Working range: 0.002 to 1.0 ppm) 
 
3.9 Results and Discussion 
 
A watch device consisting of one sodium PVC membrane electrode and one Ag/AgCl 
electrode was used for the clinical trial.  Its manufacture was described previously in 
detail from Figure 3.18 to Figure 3.23.  The silver wires from both electrodes were 
connected to high quality shielded cable via a 2-way HE14 socket, to transfer signals 
to a PC via a shielded box with an impedance correction circuit, enabling continuous 
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monitoring of the sensor signals during standard and sample analysis.  The software 
allows the monitoring of four channels at once, but in this case only one indicator 
electrode channel was employed.  The sodium electrode was connected to this 
channel and the chloride pseudo-reference electrode was connected to the reference 
channel.  The flow channels in the array were hooked up to capillary tubing and a 
peristaltic pump so that samples and standards could be passed through the device.  
 
The device was first allowed to condition overnight, from dry.  The signals from the 
electrodes were monitored and recorded continuously to monitor the hydration of the 
sodium electrode.  The trace obtained is shown in Figure 3.48.     
 
 
Figure 3.48 Response trace from device left to condition from dry overnight.  
 
The overnight conditioning solution used was the lowest concentration (20 mM) NaCl 
standard.  As can be seen, after approximately 8 hours the device reaches a steady-
state voltage at equilibrium. The main graph is the conditioning of the device from 
dry.  The smaller inset graph with the red border is a more detailed look at the 
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conditioning trace with a smaller x-axis scale, after the initial spikes and noise.  It 
shows the signal increasing as the sub-membrane hydrogel hydrates until an 
equilibrium steady-state signal is obtained.   
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Figure 3.49 Response trace from LabVIEW imported into Microsoft Excel.   
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The experimental response trace in Figure 3.49 follows the format of the many other 
similar traces throughout this document, for the previous CF trial, the simulated CF 
trial, and indeed the calibration traces in this chapter in Figure 3.45, Figure 3.46 and 
Figure 3.47.  The trace can be followed from left to right, and each horizontal portion 
of the graph represents the response of the device to a particular solution.  The first 
solution is the 20 mM standard, followed by the 40 mM standard, then the 60, 80 and 
100 mM standard solutions.  This 5-point calibration from 20 to 100 mM NaCl is 
repeated.  The 20 mM standard was then re-analysed, followed by the analysis of each 
of the sweat samples.  The 20 mM baseline standard (denoted by the “*” asterisk 
symbol) was re-analysed again periodically between sample analyses to establish a 
continuous base line.  Finally, the 5 standard solutions were again passed through the 
array in a third and final 5-point calibration.  
 
The data from the three calibrations was tabulated (Table 3.5) and the average 
responses were calculated and used to construct the calibration curve in Figure 3.50.  
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Figure 3.50 Standard Calibration Curve (20 to 100 mM) generated from the triplicate 
trial calibration data.  
 
Figure 3.49 shows the response of the device to the standards and samples in 
sequence.  All solutions were pumped through the device using a peristaltic pump 
connected to the capillary tubing in the device flow channels (see Figure 3.13).  The 
device was flushed with each standard solution for approximately 20 seconds using 
the peristaltic pump’s high speed flush mode, and the data acquisition paused during 
this solution changeover.  It was not possible to flush the sample chamber with each 
sweat sample so liberally and for such a length of time because of sample volume 
constraints, though with a sample chamber volume of approximately 7.2 µl, and 40 µl 
of sample to work with, there was adequate margin to ensure complete filling of the 
chamber for each sample.  The calibration curve in Figure 3.50 shows excellent 
linearity and repeatability, with the slope as expected.  Error bars are included and are 
hidden by the sample points.  The standard deviations [see Table 3.5] are also very 
encouraging at generally less than 1mV.  The notable exception to that is the 20 mM 
standard.  As can be seen from the trace, the 20 mM standard was used to set the base 
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line and was analysed continuously between samples and at the beginning and end of 
each calibration.  Considerably more time could have been expended in allowing the 
20 mM standard solution signal to equilibrate each time it was analysed as it does 
exhibit a good deal of variation across the bottom of the trace and this is reflected in 
the standard deviation value.  The standard deviation value calculated in Table 3.5 
however was only calculated from three of the values obtained for the 20 mM 
standard, namely the values from the three calibrations.  If the standard deviation for 
the 20 mM standard is calculated for the entire base line, a lower value of 3.05 mV is 
obtained.  Again if the signal had been allowed to equilibrate longer each time it was 
analysed, this would be further improved.  Another reason perhaps for the higher 
standard deviation of the 20mM standard is the frequency with which it was analysed, 
making it more susceptible to error due to contamination during solution changeover. 
 
Standard      Calibration  St. Dev. 
(mM)    ai  log ai  #1 #2 #3  Average   (n=3) 
20 0.017 -1.761  -191.1 -182.9 -180.7  -184.8  5.50 
40 0.033 -1.480  -157.8 -158.8 -157.6  -158.1  0.66 
60 0.048 -1.320  -138.4 -139.6 -139.7  -139.2  0.72 
80 0.063 -1.204  -128.3 -126.7 -126.7  -127.2  0.90 
100 0.077 -1.115  -116.9 -114.4 -115.3  -115.5  1.30 
 
Table 3.5 Data used to generate the standard curve in Figure 3.50 
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Figure 3.51 Sample activities calculated from the calibration curve and projected onto 
the curve to illustrate the separation of the CF samples from the normal sweat 
samples.   
 
Figure 3.51 shows the sample diagnoses on the basis of the watch results.  The dotted 
red line indicates the expected mV response for a 50 mM Na+ and Cl- solution, and 
therefore equates to an approximate diagnostic cut-off.  Normal samples are expected 
to fall below this line and CF positives above it.  The graph shows the CF normal 
samples represented by the green circles to be well clustered together and well below 
the diagnostic cut-off point.  Similarly, with one exception (#19) the positive samples 
represented by the red crosses are also clustered together and they are above the red 
line, indicating that they are correctly diagnosed as CF positive samples.  In general 
therefore clear separation of the normal and positive samples was achieved, and all of 
the samples, except one, were assigned a diagnosis consistent with their source 
population, i.e. all samples taken from a normal population were diagnosed as normal, 
and all samples taken from a CF positive population were diagnosed as positive with 
the exception of samples #19.  Sample #19 is marked with a red cross because it was 
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known to have been sampled from a CF positive population, but on the basis of the 
watch results it has been diagnosed as borderline normal.   
 
All of the samples are correctly diagnosed therefore bar one, sample #19, which as 
indicated on the graph falls just below the diagnostic cut-off point indicated by the 
dotted red line.  This does not automatically infer analytical error or failure on the part 
of the watch device.  False positives and false negatives are not unheard of and may 
be attributed to a procedural error at any point from sampling to analysis, or the 
patient may in fact have borderline sweat electrolyte levels with or without CF.  In 
borderline cases re-tests are generally carried out and indeed in any sweat-test based 
diagnosis, at least two sweat tests must be carried out and be in agreement with each 
other.  
 
In this case sample #19 was taken from a CF positive population and is expected 
therefore to have sodium and chloride activities consistent with a CF positive 
diagnosis.  This does not seem to be the case, based on the sweat watch results (Figure 
3.51).  However, this apparent misdiagnosis is mirrored by the flame emission results 
in Figure 3.52, which show a borderline sodium ion concentration for sample #19.  
Also in the titration results (Figure 3.53) the chloride ion concentration of sample #19 
is at the lower end of the cluster of CF positive samples.  These relatively low 
concentrations of sodium and chloride as indicated by the watch device and sample 
#19 is therefore a genuine borderline result.  
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Figure 3.52 Sodium AAS reference method data 
 
The AAS data for sodium, seen in Figure 3.52, shows a degree of overlap between the 
CF and the normal samples.  Sodium is not as discriminatory as chloride in CF 
diagnosis.  As before, the red crosses represent the CF positive samples while the 
green circles represent the normal sweat samples.  The small black circles represent 
the 5 standard solutions used for calibration.  Again, generally speaking, the normal 
samples are clustered together in the lower portion of the graph and below the 50mM 
cut off, which is as expected.  The CF positive samples are higher up in the 
concentration range and generally fall between the black circles representing the 60 
and 80 mM standards, which is the expected concentration range for CF positive 
sweat samples.  Interestingly, the sample that was diagnosed as borderline by the 
sweat watch results is also borderline for these AAS results, namely sample #19.  
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Standard Abs. RSD Conc. Conc. 
 mean (%) (ppm) (mM) 
        
  
0 0.011 2.1 0.000 0
1 0.170 7.6 0.059 20
2 0.229 0.5 0.117 40
3 0.386 0.1 0.351 60
4 0.612 1.6 0.585 80
5 0.902 0.1 0.936 100
     
     
 
Sample Abs. RSD Conc. Conc. 
 mean (%) (ppm) (mM) 
        
  
1 0.238 2 0.143 24.46
2 0.165 1.3 0.055 9.47
3 0.522 0.3 0.484 82.77
4 0.121 0.1 0.003 0.43
5 0.469 2.4 0.421 71.89
6 0.270 2.7 0.182 31.03
7 0.280 0.2 0.194 33.08
8 0.310 0.7 0.230 39.24
9 0.414 2.7 0.354 60.59
10 0.329 0.1 0.252 43.14
11 0.325 0.3 0.248 42.32
12 0.342 0.2 0.268 45.81
13 0.328 2.7 0.251 42.94
14 0.373 0.7 0.305 52.18
15 0.230 1.2 0.133 22.81
16 0.210 10.2 0.109 18.71
17 0.342 5.3 0.268 45.81
18 0.321 7.1 0.243 41.50
19 0.359 4.1 0.288 49.30
20 0.426 0.4 0.369 63.06
21 0.499 2.8 0.457 78.05
    
 
Table 3.6 AAS data for standards and samples.  Sodium mM concentrations are 
calculated.  The values obtained are generally consistent with expected sweat sodium 
levels (>50mM for CF and <50mM for normal). 
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Figure 3.53 Mohr titration chloride-ion concentration data showing good separation of 
positive and negative sweat samples.  
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Sample  Vol AgNO3 Conc. (mM)
      
   
1 0.11 55 
2 0.08 40 
3 0.23 115 
4 0.06 30 
5 0.19 95 
6 0.09 45 
7 0.07 35 
8 0.10 50 
9 0.17 85 
10 0.07 35 
11 0.07 35 
12 0.11 55 
13 0.09 45 
14 0.06 30 
15 0.09 45 
16 0.04 20 
17 0.08 40 
18 0.07 35 
19 0.18 90 
20 0.20 100 
21 0.25 125 
  
    
 
Table 3.7 Chloride data from Mohr titration.  Sample chloride concentrations were 
calculated from the titration data.   
 
The mM values for chloride ion in Table 3.7, and the graphical separation of the two 
sample populations in Figure 3.53, illustrate well the innate superiority of the chloride 
ion in discriminating between positive and negative CF sweat samples.  Normal sweat 
samples all show chloride levels below 60 mM and the CF positive are all above 80 
mM with half of them over 100 mM.  This amounts to a clear separation of the two 
sample groups.  The lowest positive sample was the same sample (#19) that was 
diagnosed as borderline negative using the other two methods.  
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Sample Population Na+ (AAS) Cl- (Mohr) CF Watch Result 
        (mM)     (mM) 
 
 
1  normal  24.5  55  normal  
2  normal  9.5  40  normal 
3  CF  82.8  115  CF 
4  normal  0.4  30  normal   
5  CF  71.9  95  CF 
6  normal  31.0  45  normal 
7  normal  33.1  35  normal 
8  normal  39.2  50  normal 
9  CF  60.6  85  CF 
10  normal  43.1  35  normal 
11  normal  42.3  35  normal 
12  normal  45.8  55  normal 
13  normal  42.9  45  normal 
14  normal  52.2  30  normal 
15  normal  22.8  45  normal 
16  normal  18.7  20  normal 
17  normal  45.8  40  normal 
18  normal  41.5  30  normal 
19  CF  49.3  90  normal 
20  CF  63.1  100  CF 
21  CF  78.0  125  CF 
 
 
Table 3.8 Summary of diagnostic results obtained from the CF watch and the two 
reference methods.  Anomalies are highlighted in bold.  In all cases, but one, the 
watch results correctly match sample with population.  Sample #19 was taken from a 
CF population but was diagnosed normal by the CF watch device.  The AAS results 
show that the sodium ion concentration in sample #19 is indeed just below the 50mM 
cut off point and this must be responsible for the watch misdiagnosis.  Sample #14 on 
the other hand is a normal sweat sample but has a sodium concentration just above the 
cut-off point and suggestive of CF.  The chloride concentration of the same sample at 
30 mM is well in the normal region however and the overall watch diagnosis is 
therefore normal.  
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Table 3.8 summarises the results obtained for all 21 sweat samples for the three 
methods used, namely flame emission AAS for sodium, Mohr titrimetric analysis for 
chloride, and the CF watch which monitored both ions.  As stated previously, the 
generally accepted cut-off levels for a CF sweat test (50mM sodium and 60mM 
chloride, above which is considered positively diagnostic of CF12) are a matter of 
continuous debate, much of which is prompted by the continued increase in the 
number of mutations for the CF gene which are being discovered all the time 
(currently in excess of 160013).  These mutations are increasingly rare and are often 
associated with milder forms of the disease, or are only associated with specific 
symptoms and not necessarily with the usual clinical presentation of the disease.  For 
a general screening program it is not possible to select a general cut-off value that will 
account for more unusual cases such as individuals from a normal population with 
elevated sodium or chloride and individuals with CF symptoms but normal sweat 
sodium or chloride.  For the purposes of the discussion of these results it is sensible 
therefore to take the generally accepted view that a positive sweat test for CF exhibits 
sweat sodium and chloride levels equal to or greater than 50mM and 60 mM 
respectively12. 
 
A further caveat is that none of the above results represent a true CF diagnosis or non-
diagnosis.  No CF diagnosis should ever be based on a single sweat test without 
reference to clinical presentation, family history, genetic mutation analysis, and at 
least two further confirmatory QPIT sweat tests.  What value these results then?  
Well, the one true diagnosis in Table 3.8 is the population from whence the samples 
came.  The success rate of the analytical methods used in matching samples to 
population (i.e. diagnostic accuracy) is perhaps the best test of those methods.  A 
 143 
correctly performed sweat test has 98% accuracy14 in this respect, therefore in the 
case of the sweat watch, 1 misdiagnosis out of 21 (95% accuracy) may be considered 
acceptable.  
 
Also, it is part of the design brief of this CF Watch to compete with methods such as: 
AAS, which requires large expensive bench-top laboratory equipment, dedicated 
laboratory space, fuel and air lines etc; and with such wet chemistry techniques as 
titrimetric analysis, which is time-consuming and labour intensive.  Therefore a 
comparison of the methods in terms of their respective abilities to predict a known 
outcome is also worthwhile.  
 
Based on the generally accepted diagnostic cut off values the CF watch correctly 
diagnosed all but one sample.  Sample 19 is classified as normal, though it came from 
a CF positive population.  The AAS result for sample 19 however is in agreement 
with this diagnosis with a sodium ion concentration just below the 50 mM cut-off.   
Generally speaking a lot of the normal population AAS results are quite close to the 
50 mM cut-off point and could be classed as borderline.  In a complete clinical 
situation all of these tests of course would be repeated at least twice more along with a 
full complement of physiological CF tests, which is beyond the scope of this study.  
But these high normal sodium levels may also be explained by the fact that they were 
taken from an adult population and it is generally accepted now that due to the 
increased sweating rates in adulthood, the threshold values used for children, are less 
applicable for adults15, and many advocate the use of higher cut-off points for adult 
sweat tests.  Raising the cut-off levels would remove most of the “normals” in this 
study from the borderline region.  
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The general diagnostic prediction success rate of the CF Watch based on these results 
is >95%, which compares well to the standard QPIT accuracy rate of 98% 9 (if 
performed correctly by a qualified, experienced tester, operating in a dedicated CF 
laboratory where the QPIT is regularly carried out).  It also fares equally well against 
established reference methods with the advantage of speed, simplicity and 
significantly lower cost, as well as the monitoring of both marker ions at once.  
 
One important point which sample #19 highlights is the lack of a traditional reference 
electrode in the watch device.  The exclusion of this reference electrode has its 
advantages in that it aids manufacture by simplifying construction of the device, less 
materials are required to construct the sensors, fewer sensors facilitate minimisation 
of the physical size of the device itself, and also there is one less sensor present to fail 
and cause problems.  The disadvantage of this set-up is that the individual sensor 
responses are inaccessible.  The response obtained contains information about the 
activities of both marker ions, but the individual chloride and sodium activities are not 
provided.  While this may not present a problem in most cases, and in this study it did 
not present a problem for >95% of the samples, it does present a problem for 
borderline cases.  The watch device diagnoses sample #19 as normal.  Had this 
researcher not been aware that sample #19 had actually originated from a CF positive 
population it is likely that no questions would have been raised about the validity of 
this result.  Contrast this with the reference method mM values for each ion.  Sample 
#19 has a sodium ion concentration of 49.3 mM and a chloride ion concentration of 
90 mM.  Based on these individual ion concentrations – a high normal and very 
borderline sodium level, and a clearly positive chloride level - sample #19 would 
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likely be correctly diagnosed CF positive, or at the very least investigated further with 
additional confirmatory sweat tests.  Therefore, inclusion of a reference electrode may 
be a consideration for the future.  Alternatively, considering the superior 
discrimination of chloride ion in separating the two populations, it might be more 
worthwhile to only monitor chloride.  The 2-sensor set-up could be maintained by 
replacing the sodium electrode with a solid-state reference-type electrode.  These and 
other theories are discussed in more detail in the following section.  
 
3.10 Future Work 
 
 
 
Figure 3.54 Response trace from the device in the analysis of a normal sweat sample.  
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Figure 3.54 is a simple experiment to show how the finished device might ideally be 
used in the future as a simple screening device, though there are a number of issues 
that need to be addressed before the device could be used in this manner in the real 
world.  To create the result in Figure 3.54, two calibration solutions were passed 
through the analytical device using a peristaltic pump and the combined signal was 
monitored, in the same manner as in the clinical trial.  The trace (as before) shows the 
device response to first a 10 mM NaCl standard and then a 100 mM NaCl standard.  
While this two-point calibration was being carried out, a non-CF volunteer was 
subjected to pilocarpine iontophoresis to generate a normal sweat sample.  On 
completion of iontophoresis, the analytical device was fitted to the adapted Wescor 
Macroduct (as described earlier in Figure 3.10 to Figure 3.13) and strapped to the 
patient’s arm at the site of iontophoresis to collect the stimulated sweat and deliver it 
to the analytical device as also described earlier in Figure 3.14.  Once the sweat had 
reached and filled the analytical chamber, the data monitoring software was 
reactivated to measure the response of the device to the sweat sample (again as usual 
the trace is not in real-time trace, monitoring of the signal was paused during solution 
changeover and restarted once a stable signal had been obtained).  In this case, the 
normal sweat sample is identified as normal relative to the two standard solutions.  
This is the device at its simplest with two calibration solutions and an immediate 
result.  To make such a device usable in the field one could pre-package the device 
pre-conditioned in one calibrant solution, along with a second calibration solution, 
and a syringe provided, to inject the solution into the device before sample analysis.   
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Data monitoring issues could also be addressed.  Data from the sensors could be 
stored locally on an SD card for analysis later, or a miniature circuit could be 
incorporated into the device which would measure the change in mV response and 
translate it into a simple “positive”, “negative”, or “borderline” result by lighting a red, 
green or orange Light Emitting Diode (LED) .  Alternatively the data could be 
transmitted wirelessly to a portable receiver/laptop computer.  Modern WPAN 
(wireless personal area network) communication protocols such as ZigBee® and 
Bluetooth® can easily replace physically bulky and restrictive serial cables, offering 
low-cost, low-power, monitoring and control of applications over a local wireless 
network.  This marriage of wearable sensors with wireless monitoring is being 
pioneered by research initiatives such as BIOTEX (Bio-sensing textiles for 
personalised health management, see www.biotex-eu.com), an EU funded project 
aiming to develop dedicated biochemical-sensing techniques to monitor body fluids, 
such as sweat, via sensors distributed on a textile substrate, and WEALTHY 
(wearable health care systems).  Textile based fluid handling systems for the real-time 
monitoring of sweat pH16, sweat sodium17, and sweat conductivity are being 
investigated and developed18,19, using a combination of moisture wicking fabrics and 
superabsorbent materials, which facilitate a capillary-action, passive pumping 
mechanism to collect the sweat as it is produced and channel it through a sensing area 
for analysis.  Applications are currently aimed primarily at the monitoring of athletes’ 
sweat electrolytes during exercise, but there are also many useful parallels for the 
Cystic Fibrosis community, for whom strenuous physical exercise may not be 
appropriate20.  Recent breakthroughs in the treatment and management of the Cystic 
Fibrosis condition have made pertinent for the Cystic Fibrosis community, the issue 
of the continuous monitoring of sweat electrolytes.  The QPIT sweat test is a 
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diagnosis.  Once CF was diagnosed there was neither need for, nor point to, further 
sweat testing of CF sufferers.  However modern drug and genetic therapies are being 
developed21,22 which can counter or mitigate the muco-viscidosis effects of Cystic 
Fibrosis by correcting the underlying cause: chloride channel deficiencies which lead 
to mis-regulation of sodium and chloride ions, resulting in the characteristic sticky 
mucus in the lungs and thickened secretions from the pancreas and liver.  These novel 
approaches are at varying clinical trial stages in a development pipeline, but progress 
is being made with such CFTR modulation drugs as PTC124 (Ataluren)23, VX-
77024,25, and VX-80926.  These drugs target the underlying genetic cause of the 
disease, for which elevated sweat sodium and chloride are a diagnostic manifestation 
and indication that the patient’s gastrointestinal system, respiratory system and 
hepatic system may also be malfunctioning, and threatening the health of the patient 
in a manner consistent with the characteristics of the Cystic Fibrosis condition.  
Therefore the ability to continuously monitor sweat electrolytes of patients 
undergoing these treatments, using a convenient and unobtrusive wearable device 
could be an invaluable tool for gauging the success of the treatment, and safe-
guarding the health of the patient.  
 
 
The direction of future development of this device depends largely on its precise 
intended use.  On the one hand there is a need for a simple and reliable CF screening 
device.  There are commercially available devices already being marketed as CF 
screening devices.  Wescor Inc. themselves market a conductivity based analyser 
complementary to the Wescor Macroduct, and now have a “Nanoduct” device which 
is claimed to be suitable for screening neonates.  Similar to the device in this study, 
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the sweat, as it is being collected, is directed straight into an analytical chamber, in 
this case a microconductivity cell, where the sweat is analysed and an immediate 
response is obtained.  Sweating rate is displayed automatically, only 3 micro litres of 
sweat are required and sweat stimulation time is shortened.  Some direct comparisons 
in the literature between the two Wescor products, the Macroduct v’s the Nanoduct, 
have found that the Nanoduct is at least as good as the larger Macroduct 27.  However, 
borderline results are generally seen more frequently using conductivity-based 
measurements28, and the American National Committee for Clinical Laboratory 
Standards, for example, does not accept conductivity as a definitive diagnostic tool29.  
With a false positive rate of 4.3% and 9.3% overall failure rate, there are few studies 
confirming the Nanoduct’s use other than as a simple bedside test requiring 
confirmation by more traditional methods.  One improvement of the Nanoduct is a 
significantly reduced failure rate caused by insufficient sweating.  Reliable results can 
be obtained from such lower sample volumes of sweat (~3µl), improving the 
insufficient sweat failure rate in one study30 to 2.7% (3 of 111) from the macro-
collection system’s 15.3%.  Similar improvements to our ISE based CF watch could 
be predicted by similarly reducing its dead volume, and therefore the sample volume 
required for analysis.   
 
It has also been shown that parents of children undergoing CF screening are subject to 
much anxiety, distress and upset, emotions which are exacerbated by longer waiting 
times for results and repeat tests31.  In the aforementioned Nanoduct study30, the quick 
receipt of the results and minimized waiting time for the parents and patients, was an 
important consideration for nearly all participants and parents.  The development and 
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use of reliable devices such as the nanoduct and our CF watch, which provide rapid 
in-situ results, is desirable from a patient & parent point of view therefore.  
 
On the other hand, there is also a need for an alternative to the Gibson and Cooke 
QPIT (quantitative pilocarpine iontophoresis sweat test).  This is the original gold 
standard test1, it’s laborious, it’s cumbersome, it’s time-consuming, but in the right 
hands it has proven reliability and accuracy and provides concentration data for both 
marker ions.  As a result it is a test that the CF community is very reluctant to discard, 
and indeed no CF diagnosis is considered complete, regardless of what simple 
screening test or sophisticated genetic test is performed, unless it is accompanied by 2 
confirmatory standard QPIT sweat tests32.  In this respect the sweat watch as it is 
presented here has an avenue of development not open to conductivity based 
analysers.  That is the individual and independent monitoring of sodium and chloride 
levels simultaneously and almost immediately.  Development of the watch in this 
direction might see the device pose a realistic alternative rather than merely a 
precursor to the standard QPIT.  The results of this chapter, and the previous chapters 
on the SendX® array, demonstrate that miniature ISE’s perform as well as or better 
than multiple large and expensive laboratory bench-top instruments and techniques in 
the analysis of sweat samples.  Analysis is faster, both ions can be monitored together, 
and they are suited to miniaturisation to enable samples to be analysed undiluted and 
without pre-treatment, and to enable direct integration with a modern sample 
collection technique such as the Macroduct.  
 
 
 
 151 
3.11 References 
 
                                                 
1
  L.E. Gibson, R.E. Cooke; Pediatrics, 1959, 23, 545-549. 
2
  C.R. Denning, N.N. Huang, L.R. Cuasay, H. Shwachman, P. Tocci, W.J. 
Warwick, L.E. Gibson; Pediatrics, 1980, 66, 752-757 
3
  B.R. Eggins; Analyst, 1993, 118, 439-442 
4
  D. Diamond, S. Walsh, J. McLaughlin, E. McAdams, D. Woolfson, D. Jones, 
M. Bonner; Electroanalysis, 1997, 9, 1318-1324 
5
  M.O. Iwunze, R. McCain; Journal of Photochemistry and Photobiology A: 
Chemistry, 1998, 112, 251 - 253 
6
  M. Constantinescu, B.C. Hilman; Laboratory Medicine, 1996, 27, 472-477 
7
  K.B. Hammond, N.L. Turcios, L.E. Gibson; Journal of Pediatrics, 1994, 124, 
255-260 
8
  A. Lynch, D. Diamond, P. Lemoine, J. McLaughlin, M. Leader; 
Electroanalysis, 1998, 10, 1096-1100 
9
  H. J. Veeze; Netherlands Journal of Medicine, 1995, 46, 271-274 
10
  E. Karadag, D. Saraydin; Turkish Journal of Chemistry, 2002, 26, 863-875 
11
  E. Karadag, Güven; Turkish Journal of Chemistry, 1997, 21, 151 
12
  L.E. Gibson, R.E. Cooke; Pediatrics, 1959, 23, 545-549. 
13
  Cystic Fibrosis Mutation Database www.genet.sickkids.on.ca 
14
  V.A. LeGrys, R.W. Burnett; Archives of Pathology and Laboratory Medicine,  
1994, 118, 865-867 
15
  B.J. Rosenstein; Clinics in Chest Medicine, 1998, 19, 423-441 
 152 
                                                                                                                                            
16
  D. Morris, S. Coyle, Y. Wu, K.T. Lau, G. Wallace, D. Diamond; Sensors and 
Actuators B, 2009, 139  231–236. 
17
  S. Coyle, K.T. Lau, N. Moyna, D. O’Gorman, D. Diamond, F. Di Francesco, 
D. Costanzo, P. Salvo, M.G. Trivella, D. E. De Rossi, N. Taccini, R. Paradiso, 
J.A. Porchet, A. Ridolfi, J. Luprano, C. Chuzel, T. Lanier, F.R. Cavalier, S. 
Schoumacker, V. Mourier, I. Chartier, R. Convert, H, De-Moncuit, C. Bini; 
IEEE Transactions on Information Technology in Biomedicine, 2010, 14, 364-
370 
18
  F. Benito-Lopez, S. Coyle, R. Byrne, A.F. Smeaton, N.E. O'Connor, D. 
Diamond; Eurosensors, Lausanne, Switzerland, 2009, 06-09. 
19
  F. Benito-Lopez, S. Coyle, R. Byrne,  A. Smeaton, N.E. O'Connor, D. 
Diamond; Procedia Chemistry, 2009, 1, 1103–1106. 
20
  B. Schazmann, D. Morris, C. Slater, S Beirne, C. Fay, R. Reuveny, N.  
Moynac, D. Diamond; Analytical Methods, 2010, 2, 342-348. 
21
  J.L. Kreindler; Pharmacology & Therapeutics, 2010, 125, 219-229. 
22
  M.T. Clunes, R.C. Boucher; Current Opinion in Pharmacology, 2008, 8, 292- 
299. 
23
  E. Kerem, S. Hirawat, S. Armoni, Y. Yaakov, D. Shoseyov, M. Cohen;  
Lancet, 2008, 372, 719-727. 
24
  F.J. Accurso, S.M. Rowe, P.R. Durie, M.W. Konstan, J. Dunitz, D.B. Hornick,  
S.D. Sagel, M.P. Boyle, A.Z. Uluer, R.B. Moss, B.W. Ramsey, S.D.  
Freedman, Q. Dong, J. Zha, A.J. Stone, E.R. Olson, C.L. Ordonez, J.P. 
Clancy, P.W. Campbell, M.A. Ashlock; Journal of Cystic Fibrosis, 2008, 8, 
S25-S25 
 153 
                                                                                                                                            
25
  F.Van Goor, S Hadida, P. Grootenhuis, B. Burton, D. Cao, T. Neuberger, A.  
Turnbull, A. Singh, J. Joubran, A. Hazlewood, J Zhou, J. McCartney, V.  
Arumugam, C. Decker, J. Yang, C. Young, E. Olson, J. Wine, R. Frizzell, M.  
Ashlock, P. Negulescu; Proceedings of the National Academy of the Sciences  
USA, 2009, 106, 18825-18830 
 
26
  M.P. Limberis; Drug Discovery Today: Therapeutic Stratagies,  2008, 5, 243-
248 
27
  J.E. Dankert-Roelse, I. Bon; Journal of Cystic Fibrosis, 2005, 4, S126-S135 
28
  M.C. Desax, R.A. Ammann, J. Hammer, M.H. Schoeni, J. Barben; European  
Journal of Pediatrics; 2008, 167, 299–304. 
29
  V.A. LeGrys, M.F. Burritt, L.E. Gibson, K.B. Hammond, K. Kraft, 
B.J. Rosenstein; 1994. National Committee for Clinical Laboratory Standards. 
Pub No C34-A2. Villanova, PA. 
30
   J. Barben, R.A. Ammann, A. Metlagel, M.H. Schoeni; Journal of  
Pediatrics, 2005, 146, 183-188 
31
  J. Moran, K. Quirk, A.J.A. Duff, K.G. Brownlee; Journal of Cystic Fibrosis,  
2007, 6, 250-254. 
32
  C.R. Denning, N.N. Huang, L.R. Cuasay, H. Shwachman, P. Tocci, W.J.  
Warwick, L.E. Gibson; Pediatrics, 1980, 66, 752-757 
